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Abstract 
Nanoparticles are structures with at least one dimension smaller than 100 nm. Nanoparticles 
are already present in hundreds of commercially available products, and the use of 
nanotechnology is expected to continue to grow both in terms of areas of application and in 
volume. Because of their small size and special physiochemical properties, the toxic 
properties of nanoparticles may be different from the bulk chemical from which they are 
derived. 
Silver nanoparticles are widely used because of their antibacterial properties, but have been 
shown to cause toxic effects both in vitro and in vivo. Generation of reactive oxygen species 
(ROS) and induction of oxidative stress is considered as the most plausible mechanism for 
silver particle toxicity, and the mitochondria have been suggested as a vulnerable target for 
silver particle induced ROS. Most available in vivo studies on silver particles have focused on 
the tissue distribution and toxicokinetics of the particles, and there are few in vivo studies 
addressing ROS as a possible mechanism for silver particle toxicity. In particular, there is a 
lack of data regarding the effects of silver particles on gene expression. 
In this thesis, we investigated the effects of 20 nm (Ag20) and 200 nm (Ag200) silver 
particles on generation of ROS and on the mitochondrial membrane potential of mouse 
embryonic fibroblasts (MEFs) in vitro. We also investigated the effects of silver particle 
exposure on the expression of (22) genes related to inflammation, oxidative stress, antioxidant 
defence, intercellular signalling and DNA damage repair the in brains and testes of mice in 
vivo using qPCR assay. Mice and MEF cells of both Ogg1+/+ (WT) and Ogg1-/- (KO) were 
used in all the experiments, as models for reduced repair capacity for oxidative DNA damage. 
Our investigation showed that silver particles of both 20 and 200 nm size induced generation 
of ROS in KO MEF cells after 24 hours exposure, with effects at lower concentrations for the 
nanoparticles. Our investigation into the effects of silver particle exposure on mitochondrial 
membrane potential was inconclusive, possibly because of nanoparticle interference with the 
assay. Gene expression analysis of brain and testis of mice treated with a single intravenous 
dose of 5 mg/kg bw silver particles (Ag20 or Ag200) showed a small up-regulation of 
antioxidant defence genes in both genotypes, with the nanoparticles causing up-regulation at 
day 1 and the microparticles (>100 nm, <100 µm) causing up-regulation at day 7. Significant 
up-regulation of ROS producing NADPH oxidases in brain suggests that this pathway may be 
involved in the toxicity. The gene expression in testis did not change markedly following 
silver particle exposure, and this suggests that the testis may be less vulnerable to the toxic 
effects of silver particles. 
Taken together, our results suggest that generation of ROS and induction of oxidative stress, 
possibly through the NADPH oxidase- or the Cd47-pathways, are responsible for the toxicity 
seen after exposure to nanoparticles both in vitro and in vivo. 
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1 Introduction 
1.1 General background 
Nanoparticles (NPs) are structures with at least one dimension being less than 100 
nanometres (nm). Although humans have been exposed to natural nanoparticles throughout 
their evolutionary history, such exposure has increased dramatically over the last century due 
to anthropogenic sources, and is likely to increase further as the possibility for engineering 
nanoparticles are being developed (Oberdorster et al., 2005b). 
Today NPs are present in hundreds of commercially available products and the number 
of applications for these particles is constantly growing. These product groups include 
cosmetics, sunscreens, paints and coatings, catalysts and lubricants, water treatments, textiles 
and sport items, medical and health care products, food products and packing (Surendiran et 
al., 2009). 
Due to  physiochemical properties of NPs attributed to their small size, chemical 
composition, surface structure, solubility, shape, and aggregation, (Nel et al., 2006) their toxic 
potential cannot be directly predicted by the properties of the corresponding bulk material 
(Oberdorster et al., 2005a;  Oberdorster, et al., 2005b). Engineered NPs are manufactured 
from a diverse group of substances each with an array of unique physicochemical 
characteristics. Hence, NPs will differ in the levels of toxicity they induce and the mechanism 
by which they exert these effects. 
The toxicity of different nanomaterials has been the focus of multiple recent studies, and 
a broad spectrum of potential hazards has been discovered. Several nanoparticles have been 
shown to be potentially neurotoxic (Sharma and Sharma, 2012), toxic to reproduction and 
development (Ema et al., 2010;  McAuliffe and Perry, 2007) and genotoxic (Rim et al., 2013). 
In addition, inhaled nanomaterials, such as carbon nanotubes, may cause pulmonary 
inflammation similar to that of e.g. asbestos fibres (Oberdorster, et al., 2005b). 
As the use of NPs constantly increasing, interaction with the environment and human 
exposure is inevitable. The impact for human health is still not well known or characterized 
and a strategy for risk assessment of these compounds is highly needed. 
 
1.1.1 Regulation of nanoparticles in the REACH-system. 
The use of chemicals in Europe is regulated by the REACH-regulation. REACH is an 
acronym for Registration, Evaluation, Authorization and restriction of Chemicals, and the 
regulation is to apply to all chemicals produced in- or imported to the European Union. In the 
REACH system, producers and importers of chemicals have to register all chemicals which 
are produced or imported in quantities greater than 1 tonne per year with documentation on 
the properties, use and potential hazards and risks presented by the substance. The level of 
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documentation required is decided by the tonnage level of which the chemical is imported or 
produced. Further, an additional documentation is required once the chemicals are imported or 
produced in quantities greater than 10, 100 or 1000 tonnes/year. These documentation 
requirements also apply to nanoparticles as long as they meet the tonnage-requirement. 
The REACH regulation was established at a time when nanomaterials were not of 
particular concern, and is designed to enable good risk assessment of bulk chemicals. Hence, 
there are few nano-specific documentation requirements, and properties that are of great 
importance to nanomaterial toxicity, such as surface chemistry, are not required for chemicals 
registered in REACH. The tonnage levels triggering the different documentation criteria is 
another problem, as most nanoparticles are used in large volumes, but low tonnage. Hence, 
few engineered nanoparticles meet the tonnage levels that trigger the higher documentation-
requirements. In fact, of the approximately 12 000 registrations in REACH, only 13 are 
registrations of nanomaterials (S. Andersen, Norwegian Environment Agency, personal 
communication October 2014). 
The European Commission, which is responsible for the REACH-regulation, is working 
on including more nano-specific documentation and test requirements in REACH. In the 
absence of proper nano-specific testing criteria that gives a good basis for risk assessment of 
nanomaterials within the REACH system, research on the toxicity of different NPs is crucial. 
 
1.2 Silver nano- and microparticles 
It is currently estimated that silver nanoparticles (AgNPs) are the nanoparticles with the 
highest degree of commercialization (Ahamed et al., 2008;  Rejeski and Lekas, 2008).  Due to 
their antibacterial properties, they are widely used for medical applications such as coating of 
medical equipment (catheters, surgical equipment and prostheses),  in wound dressings, and, 
of increasing importance, in drug delivery (Kumari and Yadav, 2011;  Soumya and Hela, 
2013).In addition to the medical applications, AgNPs are used in a number of household 
products where antibacterial properties are desired. AgNPs are used as detergents, in wall 
paints, textiles and cosmetics, as well as in the lining of washing machines, dishwashers and 
refrigerators (Edwards-Jones, 2009). This wide use of AgNPs in consumer and medical 
products may lead to possible exposure through the gastrointestinal tract, the respiratory 
system and directly through the bloodstream as for some of the medical applications. 
AgNPs have been shown to be toxic to a number of animal species and cultured cells 
(Gaiser et al., 2013;  Johnston et al., 2010).  Ag-particle toxicity has often been associated 
with ion release, generation of reactive oxygen species and induction of oxidative stress 
(Johnston, et al., 2010). Examples for both inflammatory (Nishanth et al., 2011) and anti-
inflammatory (Wong et al., 2009) effects of AgNPs have been reported, and there are also 
conflicting results with regards to the ability of AgNPs to cause oxidative stress (Nishanth, et 
al., 2011;  Powers et al., 2011). The physicochemical characteristics of the NPs, such as size, 
shape, and solubility, and also the choice of model, exposure times, and concentrations are 
maybe the reason for these conflicting results. 
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There is also an ongoing discussion on whether the toxic effects seen after exposure to 
AgNPs are due to the nanoparticles themselves, or the release of silver ions (Ag+) from the 
particles (Wijnhoven et al., 2009), or both (Lubick, 2008). A recent study investigating the 
changes in gene expression levels in human lung epithelial cells after exposure to both AgNPs 
and Ag ions (in the form of silver nitrate, AgNO3, which dissolves into Ag+ and NO3- in 
solution), found a considerable difference in the response (Foldbjerg et al., 2012). Foldbjerg et 
al. (2012) observed up-regulation of more than 1000 genes in cells treated with AgNPs 
compared with 133 genes in cells treated with Ag+ ions. This suggests that the Ag-particles 
themselves directly contribute to toxicity in a way that cannot solely be explained by the 
release of silver ions. 
 
1.2.1 Toxicokinetics of silver particles 
The risk of dermal, inhalation or ingestion exposure to silver nano- and microparticles 
(Ag-particles) are all relevant due to the commercial use of Ag-particles (Johnston, et al., 
2010). Direct exposure of organs to NPs through the bloodstream is likely for medical 
applications, and there is potential for NPs to reach the bloodstream through inhalation 
(Muhlfeld et al., 2008), through the skin (Korani et al., 2011), or via the gastrointestinal tract 
(Schleh et al., 2013). A schematic overview of the fate of Ag-particles in the body is shown in 
figure 1.2.1. 
 
Figure 1.2.1: Toxicokinetics of silver nanoparticles. A schematic representation of the fate of silver 
nanoparticles in the body. Adapted from Kruszewski et al. (2011). 
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The liver appears to be the primary target organ of Ag-particles through all routes of 
exposure, but Ag-particles are also found in the spleen, lungs, skin, brain, testes, and kidneys 
(McAuliffe & Perry, 2007). A dose-dependent distribution of Ag-particles to different tissues 
is shown both after single dose (Dziendzikowska et al., 2012) and repeated dose studies (Kim 
et al., 2008;  Park et al., 2010). These studies show that Ag-particles are able to cross both the 
blood-brain barrier and the blood-testes barrier. 
Cellular uptake of Ag nanoparticles occurs by pinocytosis, endocytosis dependent on 
caveolae and lipid raft composition, clathrin-dependent endocytosis and phagocytosis 
(AshaRani et al., 2009). Intracellularly, Ag-particles appear to be uniformly distributed, and 
have been found in the cytosol, mitochondria and nucleus (AshaRani, Low Kah Mun, Hande, 
& Valiyaveettil, 2009). The uptake kinetics, intracellular localization and exocytosis are 
dependent on the size, surface characteristics (including coating type, if any), the ability of the 
nanoparticles to form aggregates, as is further discussed in section 1.5.1), as well as the cell 
type (Bartłomiejczyk, Lankoff, Kruszewski, & Szumiel, 2013). 
Orally administered Ag-particles are mainly excreted through faeces, suggesting low 
bioavailability (Park, 2013), but also to some degree through urine (Dziendzikowska, et al., 
2012). Excretion through faeces is the main route of excretion of Ag-particles after 
intravenous exposure (Park et al., 2011). Dziendzikowska, et al. (2012) observed that the 
excretion of Ag in urine and faeces was much lower in rats treated with 200nm Ag-particles 
than with 20nm Ag-particles, suggesting that larger particles are less available for excretion. 
 
1.3 Oxidative stress, antioxidant defence and DNA damage-repair 
1.3.1 Oxidative stress 
Generation of ROS and the induction of oxidative stress are considered the most 
plausible mechanism of toxicity for Ag nanoparticles (Foldbjerg et al., 2011). ROS are highly 
reactive compounds which may bind to biological molecules, thereby causing damage. 
Examples of ROS products are superoxide (O2•-), hydroperoxyl radicals (HO2-), hydrogen 
peroxide (H2O2) and hydroxyl radicals (•OH). ROS are regularly generated at low levels as 
by-products of normal cellular processes, such as aerobic respiration and other O2 consuming- 
or producing processes. ROS are also by-products of cytochrome P-450-mediated 
biotransformations, which are important detoxification pathways, and may be generated by 
specialized cells-types involved in the defence against invading microorganisms. 
Neutrophils, eosinophils, monocytes, macrophages and brain microglia produce ROS 
through the NADPH oxidase enzyme (Babior, 2004;  Bianca et al., 1999;  Sankarapandi et al., 
1998), and use this to combat invading microorganisms. NADPH oxidase is a complex 
enzyme consisting of five subunits (figure 1.3.1) that catalyses the production of superoxide 
from oxygen and NADPH. Activation of the enzyme involves in the phosphorylation of one 
of the cytosolic components. Proinflammatory cytokines such as TNF and Il-1β have been 
reported to initiate NADPH oxidase activation in microglia of the brain (Mander et al., 2006). 
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NADPH oxidase activity have been suggested as a possible mechanism for neurodegeneration 
in neuronal diseases such as Parkinson’s disease (Myhre et al., 2013), and as a possible 
mechanism for toxicity caused by nanoparticles (Mo et al., 2009). 
 
Figure 1.3.1: Nanoparticles, along with other chemical stress and aging may alter microglia reactivity and 
activation of the phagocytic NADPH oxidase complex. (a) Stimulation of microglia induces the parallel 
activation of oxidase components within the cytoplasm. This activation causes the phosphorylation of the 
p47phox and p67phox subunits of the NADPH oxidase complex. These subunits then translocate to the 
membrane where they interact with the p22phox and gp91phox (NOX) subunits to initiate ROS production (b). 
Excessive or prolonged inflammation (e.g., IL-1, IL-6, TNF-) (c) and ROS resulting from increased microglial 
activation may contribute to neuronal damage (d). In addition, chemicals can damage complex I in mitochondria 
(e) and induce deleterious changes to neurons by ROS generation and ATP depletion. The figure is adapted from 
Myhre, et al. (2013) 
Due to this inherent ROS-generation, mammalian cells have a large number of 
antioxidant defences, both enzymatic and non-enzymatic, to counter the toxic ROS-molecules 
(see section 1.3.2). Oxidative stress is the state in which the activity of ROS overwhelms the 
cellular antioxidant mechanisms’ capacity to prevent damage. Oxidative stress may be the 
result of either a decrease in the defensive mechanisms or an increase of intracellular ROS. In 
either way, the result is potential damage to biological molecules and activation of specific 
biological signaling pathways. 
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1.3.2 Antioxidant defence 
Cells have a number of both enzymatic and non-enzymatic antioxidant mechanisms. 
The enzymatic defence includes superoxide dismutases (Sod) that converts O2-• to H2O2, 
catalases and peroxidases that detoxify peroxides such as H2O2 (shown in figure 1.3.2), and 
enzymes involved in the production and maintenance of reduced glutathione, an intracellular 
antioxidant. 
In addition to the enzymatic defences, there are a number of antioxidants, some of the 
obtained via food, protect the cell by reacting with and detoxifying ROS. 
Figure 1.3.2: Antioxidant defence enzymes: Detoxification of superoxide radical (O2-•) by superoxide 
dismutase (SOD) and hydrogen peroxide (H2O2/HOOH) by glutathione peroxidase (GPX), peroxiredoxin 
(Prx(SH)2) and catalase (CAT).  Adapted from Casarett et al. (2008). 
 
1.3.3 DNA damage repair pathway 
The main concern of oxidative stress is the attack of ROS on biological molecules. 
Proteins, lipids in the membrane and DNA are main targets. DNA damage caused by ROS 
includes a multitude of oxidized base lesions, abasic sites, single and double-strand breaks 
(Ahamed, et al., 2008). Oxidation of guanine may generate 7,8-dihydro-8-oxoguanine (8-
oxoG), which is highly mutagenic because it can pair with adenine as well as cytosine. A 
base-pair with adenine gives rise to a G:C to T:A transversions (Cheng et al., 1992). 
The most prevalent repair mechanism in which damaged bases are removed from the 
DNA is the base excision repair (BER) and the nucleotide excision repair (NER) pathways. In 
the BER pathway, only the damaged base is removed by lesion-specific enzymes called a 
glycosylases (Seeberg et al., 1995). In NER pathways, a section of bases around the damaged 
base is removed. In both repair mechanisms, the strand opposing the damaged base serves as a 
template for DNA polymerase and DNA ligase enzymes to restore the intact DNA strand. 
7 
 
The main enzyme responsible for removing 8-OxoG lesions is the 8-OxoGuanine DNA 
glycosylase 1 (Ogg1) enzyme (Krokan et al., 2000). The Ogg1 enzyme removes the 8-OxoG 
base-paired with a C, and the DNA backbone is subsequently cleaved at the abasic site (AP 
site) by the human AP endonuclease 1 enzyme (encoded by the Apex1 gene). Even though 
Ogg1 is the main enzyme responsible for removal of 8-OxoG lesions, there are other 
glycosylases, such as Nei-like proteins (Neil1, Neil2 and Neil3) which are capable of 
removing the 8-OxoG lesions, and these enzymes are therefore regarded as back-up systems 
(Katafuchi et al., 2004). 
 
Figure 1.3.3: Schematic representation of the base excision repair (BER) mechanism. An outline of the base 
excision repair (BER) pathway.  N-glycosylases include Ogg1, Neil1, Neil2 and Neil3. Abbreviations in 
chronological order: HAP1, human AP endonuclease 1; Polh, DNA polymerase h; XRCC1, X-ray cross 
complementing protein 1; LigIII, DNA ligase III; PCNA, proliferating cell nuclear antigen; RFC, replication 
factor C; Poly –(, DNA polymerase y –(; FEN1, Flap endonuclease; Lig1, DNA ligase 1. Adapted from Olsen et 
al. (2005). 
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1.4 Organs 
Investigation of the effects of Ag-particles exposure on the gene expression level of 
some selected genes of brain, testis, liver and lung, from mice has been performed in this 
thesis. Due to limited time, it was not possible to analyse all these samples with quantitative 
real-time polymerase chain reaction (qPCR). We therefore chose to limit the analysis of gene 
expression levels to the samples from brain and testis tissues. Both the brain and testes are 
organs with important functions that are vulnerable to toxicants, and therefore, are protected 
by the blood-brain- and the blood-testis barrier, respectively.  It has been reported that Ag-
particles at the nanoscale are able to cross both these barriers (see section 1.2.1). 
 
1.4.1 Brain 
The brain serves as the centre of the nervous system, and is regarded as the most 
complex organ of the human body. The brain is particularly susceptible to oxidative damage, 
due to a number of reasons. The brain has a very high demand for oxygen and though it 
accounts for only a few percent of the body weight, it accounts for about 20 % of the total 
oxygen consumption of the body. The brain has reduced enzymatic defence against ROS 
compared with other tissues, with low catalase- and moderate glutathione peroxidase activity 
(Marklund et al., 1982) and low levels of superoxide dismutase activity (Marklund, 1984). 
Access of chemicals from blood to the brain is restricted by the blood-brain barrier 
(BBB). The BBB is a highly selective permeability barrier that separates the circulating blood 
from the brain tissue. The BBB is formed by the endothelial cells of blood capillaries in the 
brain. Tight junctions between the cells prevent diffusion of polar compounds through the 
intercellular space between the cells. Diffusion of lipophilic compounds is restricted by a 
large number of ATP binding cassette-transporters (ABC-transporters) present in the 
endothelial cell membranes pumping xenobiotics from the endothelial cells back into the 
blood. 
 
Figure 1.4.1: Schematic representation of the blood-brain barrier. The figure shows the presence of tight 
junctions between the endothelial cells, as well as the ABC-transporters in the blood-facing membranes of the 
endothelial cells. The ABC-transporters listed in the figure are P-gp: P-glycoprotein, BCRP: Breast Cancer 
Resistant protein, Mrp1: Multidrug resistance protein 1, Mrp2: Multidrug resistance protein 2 and Oatp2: 
Organic-anion transporting peptide 2. Figure adapted from Casarett, et al. (2008) 
9 
 
The BBB allows the passage of water, some gases, and lipid soluble molecules by 
passive diffusion, as well as the selective transport of necessary molecules such as glucose 
and amino acids. Several studies have shown that Ag-particles are able to cross the BBB 
(Sharma et al., 2010) and Dziendzikowska et al. (2012) showed that Ag-particles of 20 nm 
and 200 nm accumulated in the brains of rats exposed to a single i.v. (intravenous) dose of 5 
mg/kg bw, reaching maximal values 28 days post exposure. 
In addition to systemic distribution of Ag-particles through the circulatory system, it has 
been shown that inhaled nanoparticles can be deposited in the nasopharyngeal region of the 
respiratory tract and from there may translocate to the brain through the olfactory nerve in rats 
(Oberdorster et al., 2004). This creates an additional way of direct exposure of nanoparticles 
to the brain, although, as is pointed out by the authors, the relevancy for human exposure must 
be treated with caution, as there are major physiological differences between the upper 
respiratory systems of humans and rats. E.g. that only 5% of the human nasal mucosa is 
olfactory epithelium as opposed to 50% in rats, and the fact that rats are obligatory nose 
breathers, whereas humans are mixed oro-nasal/nasal breathers (Oberdorster, et al., 2004). It 
has been showed that Ag-particles may cause inflammation and disruption of the BBB and 
thereby increase its permeability in vitro (Trickler et al., 2010). Sharma, et al. (2010) showed 
that exposure to 50-60 nm AgNPs caused disruption of the BBB, and hence may induce brain 
oedema, in vivo, 
Concern have been voiced over the potential of Ag-particles to reach the hippocampal 
area of the brain which is central for processes linked to memory formation and learning 
(Myhre et al., 2013). Liu et al. (2012) observed increased concentrations of ROS in 
hippocampal homogenate from male Wistar rats treated with Ag particle suspension nasal 
drops every two days for 14 consecutive days in both the low dose (3 mg/kg bw) and high 
dose (30 mg/kg bw) groups. They also observed histopathological changes in the 
hippocampus, along with reduced performance in the Morris water maze test for spatial 
cognition. In contrast, Liu et al. (2013) observed no impact on the spatial cognition of rats 
given daily intraperitoneal administration of Ag-particles every day for 7 days. 
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1.4.2 Testis 
Negative effects on male reproductive health have been observed in western countries in 
the last decades, as revealed by the increased incidence of testicular cancer, genital 
abnormalities, poor sperm quality and reduced fertility. These male reproductive disorders are 
believed to be caused by a combination of lifestyle and environmental factors (Boisen et al., 
2001). 
 
Figure 1.4.2 Anatomy of the testis. The seminiferous tubules are coiled loops connected to the rete testis, which 
leads to the epididymis. The epididymis consists of the caput and cauda epididymis that leads to the vas deferens. 
Adapted from (Silverthorn et al., 2009). 
The testicle is a vital part of the male reproductive organ, and is responsible for the 
production of produce sperm cells and steroid hormones, such as testosterone. The testis is 
physically enclosed by a capsule (tunica albuginea), and further subdivided into the 
intertubular-/interstitial compartment and the seminiferous tubule compartment (figure 1.4.2). 
The interstitial compartment contains Leydig cells, responsible for production of steroid 
hormones, mast cells, macrophages and the blood- and lymphatic-vessels. The seminiferous 
tubule compartment contains the germ cells and the Sertoli cells, and it is where the 
production of sperm cells, the spermatogenesis, takes place. The Sertoli cells protect the 
maturing germ cells from harmful influences via the blood-testis barrier (BTB) (Bart et al., 
2002). This barrier consists of tight junctions between the Sertoli cells and efflux transporters 
pumping xenobiotics out of the Sertoli cells (figure 1.4.2). The BTB is generated as the first 
rounds of spermatogenesis are initiated at puberty. 
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Figure 1.4.2:  Schematic overview of tight junctions (e), P-glycoprotein (Pgp), and Multidrug resistance 
protein 1 (MRP1) in relation to their function in the blood–testis barrier. a=myoid-cell layer; b=Sertoli 
cell; c=maturing germ cells; d=mature germ cell; e=tight junction. The figure is adapted with modifications 
from Bart, et al. (2002). 
Several studies have reported that nanoparticles are capable of crossing the BTB (De 
Jong et al., 2008; Lankveld et al., 2010), and Ag-particles may contribute to the overall 
environmental stress which the testicle cells are subjected to (Ema, et al., 2010). It has 
previously been found that Ag-particles cause cytotoxicity in testicular cells in vitro (Asare et 
al., 2012), and DNA strand breaks (Asare et al., 2014) as well as possible altering of Leydig 
cell function (Garcia-Reyero et al., 2014) in vivo. 
 
1.5 Methodological considerations 
1.5.1 Choice of silver particles and exposure doses 
The same Ag-particles were used both in the in vitro cell culture study and in the in vivo 
animal study. The size of the Ag-particles used in the studies were ~20 nm (hereafter referred 
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to as Ag20), and ~200 nm (hereafter referred to as Ag200), and both Ag-particle types were 
purchased from Plasmachem GmbH, Germany, and they have spherical in shape. 
These Ag-particles were selected based on literature search (e.g. Asare et al., 2012;  
Dziendzikowska, et al., 2012;  Gromadzka-Ostrowska et al., 2012), and both Ag-particles 
have been extensively characterized (Lankoff et al., 2012). 
 
Figure 1.5.1: Scanning- (SEM) and transmission electron microscope (TEM) images of Ag20- and Ag200-
particles. (A) SEM image of Ag20-particles, (B) SEM image of Ag200-particles, (C) TEM image of Ag20-
particles, (D) TEM image of Ag200-particles. 
In the in vitro cell culture studies, different concentrations of both Ag20 and Ag200-
particles were used and their effects were compared. The concentration range between 10 
µg/mL and 200 µg/mL was selected based on literature (Asare, et al., 2012;  Lee et al., 2014). 
The single i.v. injection dose of 5 mg/kg body weight (bw) was selected based on previous 
studies (Dziendzikowska, et al., 2012), and may be regarded as a relatively moderate dose 
compared with the results of other studies (Kim et al., 2010;  Tiwari et al., 2011). A NOAEL 
(no observable adverse effect level) of 30 mg/kg bw and a LOAEL (lowest observable 
adverse effect level) of 125 mg/kg bw has been suggested after a subchronic oral toxicity 
study (Kim et al., 2010). The gastrointestinal uptake of Ag-particles has been estimated to be 
between 1.2 – 4.2 % in oral toxicity studies using doses of 1 - 10 mg/kq bw with greater 
uptake with the highest dose (Lin et al., 2014). Our i.v. dose of 5 mg/kg bw should therefore 
be slightly lower than the effective dose of the LOAEL suggested byKim, et al. (2010), and 
may therefore be regarded as moderate. Intravenous exposure was also regarded as a relevant 
route of exposure for the Ag-particles used in medical applications. A study investigating the 
blood silver levels of burn patients treated with containing wound dressings showed that the 
blood levels were increased in the course of the treatment, but that these increases were not 
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associated with signs of toxicity (Vlachou et al., 2007). In addition, Ag-particles have also 
been shown to reach the circulatory system via other exposure routes (Johnston, et al., 2010). 
Fresh preparation of Ag-particles before each exposure is important, as Ag-particles 
tend to agglomerate in suspension (Bihari et al., 2008). A detailed description of particle 
preparation is presented in section 2.1.2. 
 
1.5.2. Mouse embryonic fibroblasts (MEFs) and the Ogg1 knock-out mouse 
model 
In vitro toxicity testing can give important mechanistic information about substances. 
As an in vitro testing is relatively cheap, and several studies can be done in parallel, it is an 
important supplement to the in vivo toxicity testing. Mouse embryonic fibroblasts (MEF) cells 
are isolated from mid-gestation mouse embryos and can either be cryopreserved until use as 
primary cells, or immortalized to a cell line. As the isolation of MEFs are relatively easy to 
perform, and as the cells can be isolated from mice with different genetic alterations, MEF 
cells are ideal for studying the effects of specific genetic mutations (Xu, 2005). 
Previous studies have showed that human male germ cells have a low capacity to repair 
certain types of oxidative DNA damage, in contrast to the highly efficient repair in rodents 
(Olsen et al., 2001;  Olsen et al., 2003). To mimic the reduced repair-capacity of human germ 
cells, mice and MEF cells with a knock out (KO) mutation at the 8-oxoguanine DNA 
glycosylase-gene (Ogg1-/-), were used along with mice and cells with the wild type (WT) 
genotype (Ogg1+/+). The mice were a generous gift from Klungland and co-workers at the 
Oslo University Hospital (Klungland et al., 1999), and the MEF cell cultures were kindly 
given to us by Professor Lars Eide and co-workers at the Oslo University Hospital. 
In addition to being a good model for the reduced repair capacity of human germ cells, 
the Ogg1 model is also relevant in the studies of other types of oxidative damage. For 
example, the Ogg1 KO mice have been used as a model for mild Parkinsonism (Cardozo-
Pelaez et al., 2012). 
 
1.5.3 Reactive oxygen species (ROS) measurement 
2,7-dichlorodihydrofluorescein (DCFH-DA) is a stable dye which diffuses passively 
through the cellular membrane. Intracellular esterase activity results in the formation of 
DCFH, a non-fluorescent compound that is trapped in the cells. DCFH is oxidized by 
hydrogen peroxide (H2O2) and other low molecular weight peroxides, to the highly 
fluorescent compound DCF. Thus, the fluorescence intensity is proportional to the amount of 
H2O2 produced by the cells, and may be measured to establish the level of ROS in the cells 
(Myhre et al., 2003). The DCFH-DA assay has been used in several previous studies of ROS 
generation caused by Ag-particles (e.g. Hussain et al., 2005;  Lee, et al., 2014;  Piao et al., 
2011). 
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1.5.4 Mitochondrial membrane potential assay 
The mitochondrial membrane potential (∆Ψm) is an important parameter for 
mitochondrial function and it can be used as a marker of early signs of apoptosis (Green and 
Reed, 1998;  Petit et al., 1995). In order to investigate the connection between ROS 
generation and apoptosis, the JC-1 mitochondrial membrane potential assay was performed 
after 24-hour exposure to Ag20- and Ag200-particles as described in section 2.1.2. The 24 
hour exposure time to Ag-particles was chosen based on our ROS-measurements, described in 
section 3.1.1. 
5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) is a 
fluorescent dye that selectively enters mitochondria and reversibly changes colour from green 
to red depending on the mitochondrial membrane potential. In healthy cells with high 
mitochondrial membrane potential, the JC-1 dye forms complexes known as J-aggregates that 
emit a red fluorescence, whereas in unhealthy cells with low ∆Ψm, the dye remains in its 
monomeric form, emitting green fluorescence. The ratio between the fluorescence intensity of 
the J-aggregates (red) to that of the JC-1 monomers (green) is used as an indicator of cell 
health according to the manufacturer’s protocol, i.e., the lower the ratio, the more cells with a 
low ∆Ψm, indicating compromised cell health. 
 
1.5.5 Gene expression analysis 
The flow of information from DNA to gene product is the fundamental principle of 
molecular biology. The genetic information contained by DNA is transcribed to mRNA 
molecules, which are then translated to proteins within the individual cells. Proteins, in turn, 
are directly responsible for cell organization and function, and may also regulate the synthesis 
of other molecules. 
When a cell is exposed to a toxic agent, it may respond by changing its normal 
processes, and this can be reflected as qualitative or quantitative changes in gene expression 
levels. A change in gene expression levels will lead to downstream changes in protein 
production encoded by these genes, and further downstream metabolic changes because of 
these proteins. In this thesis, the effects of exposure to Ag-particles on gene expression levels 
in WT and KO mice were investigated. 
For gene expression analysis to give a correct image of the RNA population in the 
samples examined, it is of high importance that the RNA extracted from the samples is of high 
quality. Low-quality RNA can seriously compromise downstream analysis (such as qPCR and 
microarray) and may lead to incorrect interpretations of the data. It is therefore essential that 
an extensive RNA quality control is performed. RNA quality encompasses both RNA purity 
(absence of contaminants such as DNA, protein, carbohydrates and lipids) and RNA integrity. 
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Compared with DNA, RNA is relatively unstable molecules which are prone to 
enzymatic, chemical or physical degradation. RNA molecules are readily degraded by 
Ribonuclease enzymes (RNases), and these enzymes present in the environment. Bacteria and 
moulds are common in both dust particles and on human skin, and they are the most common 
sources of RNases. It is therefore essential to provide an RNase-free environment throughout 
the RNA-isolation procedure and in any subsequent handling of RNA-samples, and this may 
be done by spraying all equipment, as well as gloves with RNase inhibitors. In addition to 
RNases from the environment, many tissues, e.g. liver, contain a large amount of RNases, 
which are activated upon thawing. Storing the RNA at very low temperatures (-80 °C), and 
keeping the samples on ice during processing, may help in preventing the RNA from being 
degraded. In addition, lysis solutions supplied with commercial RNA isolation kits usually 
contains RNase inhibitors such as guanidine thiocyanate. 
Quick and efficient tissue homogenization is an important factor which may influence 
the RNA quality and yield. To establish a quick and robust homogenization protocol, we 
compared two homogenization methods: Ultra-Turrax (IKA-Werke, Germany) and Precellys 
(Bertin Technologies, France) in a pilot study. The results from this study are presented in 
section 3.2.1. 
RNA cannot serve as templates in the qPCR assay. Therefore, the isolated RNA has to 
be copied into complementary DNA (cDNA) by a reverse transcription (RT) reaction. The RT 
reaction should result in a cDNA population that is representative for the original mRNA 
population of the sample. The RT reaction is still not completely understood, and is 
considered to represent the uncertain step in gene expression analysis (Malboeuf et al., 2001;  
Zhang et al., 2001). 
The actual quantitative real-time PCR (qPCR) is the real time quantification of the 
cDNA created in the RT-reaction, and amplified by PCR. The polymerase chain reaction 
(PCR) was invented in 1987 (Mullis; et al., 1987) to amplify fragments of DNA. The PCR 
reaction relies on the ability of heat-stable DNA polymerase enzymes, such as Taq-
polymerase, to extend short single-stranded synthetic oligonucleotides (primers) during 
repeated cycles heating and cooling of the reaction for DNA melting and enzymatic 
replication of the DNA, a process known as thermal cycling. The primers are designed to 
specifically bind to the DNA fragment to be amplified, and the DNA polymerase uses these 
primers as templates for DNA extension. As the PCR reaction progresses, the DNA fragments 
that are generated are themselves used as templates for further replication, thus leading to an 
exponential increase in DNA fragments. Each cycle doubles the amount of target DNA, 
proceeding until one of the reaction ingredients becomes limiting, upon which the reaction 
reaches a plateau. 
The qPCR was developed by Higuchi et al. (1992) and measures, as suggested by the 
method name, the quantitative increase in PCR products in a real time. A master mix, 
containing a fluorescent probe marker, such as SYBR Green, a heat stable polymerase, 
deoxyribonucleotides (dNTPs), and magnesium salt is mixed with diluted sample cDNA, and 
during the repeated heating and cooling of the qPCR reaction, the fluorescent probe binds to 
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the double stranded helix of produced DNA and the fluorescence is measured after each cycle. 
The quantification cycle (Cq) is the fractional cycle number at which the fluorescence exceeds a 
fixed threshold, and how quickly a sample reaches this threshold depends on the amount of cDNA 
for the specific gene sequence in the original sample. The Cq value is therefore an estimate of the 
amount of RNA in the cells or tissue. The gene expression analysis is therefore a good way to 
estimate the toxic response of cells at a molecular level (Stevens et al., 2000). Though the 
results from gene expression analysis should be extrapolated with caution, gene expression 
analysis may be a useful biomarker for the early stages of toxicity, and also may be of great 
use in investigating mechanism of toxicity. 
 
1.6 Aims 
The uses of nanotechnology are expanding, and as a result humans are exposed to increasing 
number of different nanomaterials. The potential human health hazards are not well 
characterized. Therefore, more knowledge about the potential health hazards by nanoparticles 
is needed. Investigating the mechanism of toxicity is a first step in understanding how these 
particles affect humans and the environment. The aim of this thesis was to evaluate oxidative 
stress as a possible mechanism of Ag-particle toxicity. More specifically, we wanted to get 
answers to the following questions: 
- Does exposure to Ag-particles contribute to ROS generation in vitro? 
- Does exposure to Ag-particles affect the mitochondrial integrity in vitro? 
- Does exposure to Ag-particles modulate the expression of genes involved in oxidative 
stress, inflammation and DNA damage repair pathways in mice? 
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2 Materials and methods 
2.1 Cell cultures 
Mouse embryonic fibroblasts (MEFs) cell lines established from mid-gestation mouse 
embryos from wild-type (Ogg1+/+) and genetically modified knockout (Ogg1-/-) mice were 
employed for the in vitro experiments. The Ogg1 gene codes for the 8-OxoGuanine DNA 
glycosylase 1 enzyme, which as described in the introduction section 1.5.2, is responsible for 
the excision of 8-oxoguanine, a mutagenic base that occurs as a result of exposure to reactive 
oxygen. The MEF cells were cryopreserved in liquid nitrogen and thawed at passage nr. 5 for 
the KO cells and nr. 8 for the WT cells. 
 
2.1.1 Culturing conditions 
The cell cultures were routinely maintained in Dulbecco’s Modified Eagle’s Medium 
(DMEM) containing 4.5 g/L Glucose, 10 % Foetal Calf Serum (FCS), 1 % 200 mM L-
Glutamine (final concentration 16.6 mM) and 1 % penicillin/streptomycin (P/S). The cells 
were grown in 75 cm2- or 175 cm2 Costar cell culture flasks (Corning Inc.) at 37 °C with 5 % 
CO2 and saturated humidity in a cell cultivator. 
MEF cells are prone to differentiate if grown at very high or very low densities. It was 
therefore important to split the cells before they exceeded 75% confluence. The cells were 
passaged when they reached ~75% confluence, using Trypsin-EDTA and counted as described 
in detail in appendix A.1.1. – A.1.3. 
 
2.1.2 Preparation of silver particles 
Ag-particles (Ag20 and Ag200) were weighed and dissolved with sterile distilled water, 
to achieve a stock solution with a concentration of 5 mg/mL. Then, the stock solution was 
sonicated on ice for 3 minutes, after which the Ag-particle solution was mixed with 10X 
bovine serum albumin (BSA) and 10X phosphate buffered saline (PBS) in a 8:1:1 ratio to 
achieve a final concentration of 2 mg Ag-particles/mL, and a final BSA concentration of 150 
mg/mL (Bihari et al., 2008). The Ag-particle solutions were further diluted in cell culture 
media to the experimental concentrations. 
 
2.1.3 Reactive oxygen species (ROS) measurement 
A main objective of this thesis was to evaluate whether the toxic effects of Ag-particles 
may be linked to the generation of reactive oxygen species (ROS). To investigate the 
generation of ROS in WT and KO MEF cells after exposure to Ag-particles in vitro, the dye 
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2,7-dichlorodihydrofluorescein (DCFH-DA) assay was employed, which is described in 
section 1.5.4. 
MEF cells were seeded in black walled 96-well plates 24 hours before exposure. Both 
WT and KO cells were seeded in 45 wells each in a 100 µL growth medium/well. The 
remaining six wells were used as blanks. Cells were treated with five different doses of Ag20- 
or Ag200 particles: 10 µg/mL, 20 µg/mL, 50 µg/mL, 100 µg/mL and 200 µg/mL. The 
experiment was performed four times with three technical replicates in each. H2O2 (1mM and 
100 µM) were used as positive controls; while vehicle treated cells were used as negative 
controls. 
After 3, 6 or 24 hour exposure, the exposure medium was removed and the cells were 
washed with 100 µL preheated PBS. Medium containing 20 µM of the dye DCFH-DA was 
then added to the cells, and further incubated at 37 °C for 20 min. Then, the medium was 
removed and the cells were washed with 100 µL PBS and another 100 µL of PBS was added. 
Fluorescence intensity was measured by the ClarioSTAR plate reader at wavelengths between 
488 and 526 nm. 
The protocol described above is as a result of many different method optimizations. We 
tried a different approach wherein the cells were grown in 12-well plates, and cells were 
harvested by gentle scraping. There were no visible ROS-measurement trends in the data 
when cells were scraped. 
 
2.1.4 Mitochondrial membrane potential assay 
Apoptosis is a cellular process involving a genetically programmed series of events 
leading to cell death. A distinctive feature of the early stages of this programmed cell death is 
the disruption of active mitochondria. This mitochondrial disruption includes changes in the 
membrane potential and alterations to the oxidation–reduction potential of the mitochondria. 
The JC-1 dye is, as described in section 1.5.5, sensitive to differences in mitochondrial 
membrane potential (∆Ψm). In healthy cells with high ∆Ψm, JC-1 forms aggregates that emit 
a red fluorescence, whereas in unhealthy cells with low ∆Ψm JC-1 will remain in the 
monomeric form and emit green fluorescence. 
MEF cells were seeded in 96-well plates 24 hours before exposure. Both WT and KO 
cells were seeded in 45 wells each in a 100 µL growth medium/well. The remaining six wells 
were used as blanks. MEF cells were treated with three different doses of Ag20- or Ag200 
particles: 10 µg/mL, 50 µg/mL and 200 µg/mL. The experiment was performed five times 
with three technical replicates in each. A H2O2 concentration of 100 µM was used as positive 
control, as this was suggested by the manufacturer, and two triplicates of untreated cells for 
each genotype were used as negative controls. 
The JC-1 staining solution was prepared according to the manufacturer’s instruction by 
diluting room temperated JC-1 reagent in pre-heated cell culture medium. The manufacturer 
advised 1:10 dilution, but noted that dilutions of 
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dilution is too strong. We diluted the JC-1 reagent 1:13,2 as this allowed us to thaw one 
aliquot of 50 µL/JC-1 reagent per independent experiment. 
After 24 hour exposure, the 10 µL of prepared JC-1 staining solution was added to each 
well. Cells were incubated with JC-1 at at 37 °C for 20 minutes. After incubation, the plate 
was centrifuged for five minutes at room temperature and 400g. After centrifugation, the 
supernatant was carefully removed, and 200 µL of assay buffer was added to each well. The 
plate was then centrifuged for another five minutes at room temperature and 400g. This step 
was repeated one more time, after which the supernatant was removed and 100 µL assay 
buffer was added to each well. Fluorescence intensity was measured by the ClarioSTAR plate 
reader at wavelengths 560/595 nm and 485/535 nm. 
 
2.2 Animals 
To get more insight into the mechanisms of toxicity of Ag-particles, the gene expression 
in the brains and testis of WT and KO mice exposed to Ag-particles at 1 and 7 days was 
analysed. As we wanted to investigate the role of the 8-oxoguanine DNA glycosylase (Ogg1) 
gene in oxidative damage repair following Ag-particle exposure, mice with of both WT and 
KO for this gene were used in the study. 
 
2.2.1 Animal models 
Animals were 8 to 12 week old and both have C57BL/6 background. The Ogg1-/- mouse 
was derived from  the C57BL/6 mice and 129SV, crossed with Big Blue® C57BL/6 mice 
(Stratagene, La Jolla, CA,USA) to achieve Ogg1-/- Big Blue® mice, obtained as a generous 
gift from Klungland and co-workers at the Oslo University Hospital. 
Breeding and care were performed in-house at the Norwegian Institute of Public Health, 
Oslo, Norway, and details are presented in appendix A.1 Isogenic Ogg1+/+ (WT) and Ogg1-/- 
strains in similar background (Big Blue® C57BL/6) were generated after backcrossing the 
Ogg1-/- mice with C57BL/6 mice (Stratagen/dark cycle. Mice were fed with standard diet and 
drinking water was provided ad libitum. The genotypes of the mice were routinely determined 
by conventional PCR-genotyping. The experiments were performed in conformity with the 
laws and regulations for animal experiments in Norway and were approved by the local 
officer of the Animal Board under the Ministry of Agriculture in Norway. 
 
2.2.2 Experimental design 
The in vivo experiment was performed at the animal facilities of the Norwegian Institute 
of Public Health at the Department of Chemicals and Radiation (MIKS) in 2010. 
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A total of 72 male mice (36 WT and 36 were KO mice), were randomly divided into 
groups of 6 mice per group. 
There were three different treatment groups per genotype per time. The treatment 
groups were as follows: Ag20 (n=6), Ag200 (n=6), and vehicle control (n=6). Because of 
technical reasons, 2 of the mice (WT vehicle control, 1 week; and WT Ag200, 1 week) could 
not be included in the experiment. 
Ag-particles were freshly prepared as described in section 2.1.2 each time and 
administered intravenously (i.v.) by the tail vein at a dose of 5 mg/kg bw. The control group 
received saline water containing PBS (10%) and BSA (10%). 
Exposure day was sat as day 0. Mice were sacrificed by cervical dislocation 1 or 7 days 
post exposure. 
 Genotype Vehicle control Ag20 Ag200 
Day 1 
WT 6 6 6 
KO 6 6 6 
Day 7 
WT 5 6 5 
KO 6 6 6 
 
Table 2.2.1: Number of animals per treatment group. Total number of mice in the experimental design was 
72, but due to technical reasons, two of the mice could not be included in the study. The final number of animals 
therefore was 70. 
 
2.2.3 Harvesting of tissues 
Tissues were harvested immediately after termination by cervical dislocation, and the 
harvested tissues were then immediately frozen on dry ice. From each mouse, the brain, liver, 
lung and testes were harvested, giving a total of four tissue samples per mouse, and a total of 
288 samples were harvested. The tissues were stored at -80°C until use. 
 
2.3 RNA isolation 
2.3.1 Tissue homogenization 
RNA is very easily degraded by a variety of Ribonucleases (RNases), and RNA 
degrading enzymes are present in the environment. Therefore, it is of high importance that all 
parts of the RNA isolation process to be done as quickly and efficiently as possible. 
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Quick and efficient tissue homogenization is an important factor in order to obtain a 
high quality RNA which can be used for downstream analysis such as qPCR assay. To 
establish a quick and robust homogenization protocol, we compared two homogenization 
methods: Ultra-Turrax (IKA-Werke, Germany) and Precellys (Bertin Technologies, France). 
After tissue homogenization, total RNA was isolated from the samples and RNA quantity and 
quality was determined as described in section 2.3.3. 
The Ultra-Turrax® T8 disperser tool is designed for homogenization of biological 
tissue-samples by means of blades which rotate at high speeds. The sample is disrupted and 
homogenized by a combination of mechanical shearing and turbulence. This was the standard 
method for homogenization of tissue used in the lab. The Ultra Turrax was run for 45 sec per 
sample, with additional time added if there were still visible pieces of tissue in the lysate. 
The Precellys®24 tissue homogenizer disrupts tissue by subjecting pre-filled lysis tubes 
with ceramic beads to high-speed multi-directional motion. The shaking movement of the 
Precellys disrupts the tissue by turbulence. The tissue sample, along with lysis solution, is 
added to a pre-filled lysing tube containing 50 pieces of 1.4 mm ceramic beads.  
The frozen tissue was packed in small aluminium-foils and was kept on dry-ice. The 
tissue samples were fragmented using a pestle while still in wrapped with the aluminium-foils 
and approximately 45 mg tissue was transferred to the pre-filled tube containing lysis solution 
(500 µL) and quickly weighed. The lysis solution was adjusted by adding 250 µL lysis 
solution per 25 grams of extra tissue weight if the tissue weight exceeded 45 mg. In 
homogenization run using the Precellys, eight samples were homogenized by using the tissue 
disruption program. The settings used were 5000 rpm for 20 sec, repeated 2 times with a 5 
second interval between the runs. Every part of the procedure was done as quickly as possible 
to prevent RNA degradation. 
For homogenization with the Ultra-Turrax, samples were inserted into the tube with 
lysis solution and the UltraTurrax was immediately turned on. The sample was homogenized 
for 45 seconds, or until there was no visible tissue debris in the sample and one sample. In the 
latter case, time of homogenization was recorded. As with the Precellys, every part of the 
procedure was performed as quickly as possible to prevent RNA degradation. 
The homogenized tissue lysates were stored at -80°C until use. 
 
2.3.2 RNA isolation 
Total RNA was extracted from the homogenized tissue lysates using the GenElute 
Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, USA), according to manufacturer’s 
instructions, with a few minor modifications. 
RNA from liver, lung and testes of the animals sacrificed at day 7 was isolated prior to 
this work at the Department of Chemicals and Radiation following the same RNA isolation 
protocol as used in this work. 
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The RNA isolation procedure is a multi-step procedure of removing cellular debris, 
DNA and other contaminants (figure 2.3.1). The homogenized tissue lysate is filtered to 
remove cellular debris and remaining pieces of tissue, and after filtration, is mixed with 
ethanol to facilitate the binding of RNA to a special RNA binding column. Repeated filtration 
and washing with different wash buffers gradually removes non-RNA material, whereas RNA 
is bound to the binding column. In the final step, the RNA is eluted and available for quality 
control and downstream analysis. As in the homogenization step, all equipment, surfaces and 
gloves were washed with the RNase inhibitor RNase Away to create an RNase-free 
environment. 
 
 
Figure 2.3.1: Procedure for isolation of RNA from tissue homogenate. For further details, refer to the 
protocol in appendix A.2. 
 
2.3.3 Analysis of RNA quantity and quality 
High quality RNA is a necessity for downstream analyses such as qPCR and microarray. 
The quantity and quality of RNA was therefore assessed before proceeding with downstream 
steps. The RNA quantity and purity of the samples were analysed using the NanoDrop1000 
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Spectrophotometer (NanoDrop Technologies, USA). The NanoDrop measures the sample’s 
absorbance of light at different wavelengths, and uses this to determine the quality and purity 
of RNA. RNA and DNA absorb light at 260 nm, and the Nanodrop software estimates the 
concentration of nucleic acids according to the absorbance at 260 nm. Proteins and phenols 
absorb light at 280, and other contaminants such as carbohydrates and salts absorb light at 230 
nm. By calculating the A260/A280- and A260/A230-ratios, the software gives an indication of 
the purity of the sample. A 260/280 ratio of around 1.8 for DNA and 2.0 for RNA indicates a 
pure sample and a 260/230 ratio below 2.0 indicates contaminants. 
The samples were measured according to the manual of the NanoDrop1000 software (v. 
3.8.1), as described in detail in appendix A.3. 
 
Figure 2.3.2: A typical nanodrop measurement for a RNA sample. The absorbance curve peaks at 260 nm 
where RNA absorbs light, and there is just one peak (additional peaks would indicate the presence of 
contaminants). Run details like RNA yield, OD260/280- and OD260/230 ratios are given on the right. The figure 
is an adapted screenshot from the Nanodrop1000 software v.3.8.1. 
RNA quality is determined by two parameters: the purity measurement, as descried 
above, and the integrity of the RNA molecules. The RNA integrity of the samples was 
measured using the Agilent 2100 Bioanalyzer and the RNA 6000 Nano Assay kit (Agilent 
Technologies, USA). The Agilent 2100 Bioanalyzer is a chip-based capillary gel-
electrophoresis, which allows for automated and objective classification of RNA integrity. 
This is done by assigning a degradation factor ranging from 1 to 10, with 1 being the most 
degraded and 10 being the most intact, to each of the RNA samples. In this way it is easy to 
compare the integrity of the samples. 
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Figure 2.3.3: Agilent Bioanalyzer electropherogram showing the regions that are indicative of RNA 
quality. The electropherogram is for intact RNA with RIN close to 10, and a ribosomal ratio (28S:18S) close to 
1.9. The figure is adapted with modifications from (Schroeder et al., 2006). 
The Agilent 2100 Bioanalyzer uses gel-electrophoresis-chips from the RNA 6000 Nano 
assay kit. Preparation protocol for the reagents and chip are listed in A.4. 
 
2.4 Gene expression analysis 
The main objective of this thesis was to investigate whether exposure to Ag20 and 
Ag200 particles affect the expression of genes related to inflammation, oxidative stress, 
antioxidant defence, intercellular signalling or DNA damage repair. To achieve this objective, 
a panel of 22 genes involved in these pathways was investigated by qPCR assay. 
 
2.4.1 cDNA synthesis by reverse transcription 
RNA molecules cannot serve as templates for the real-time quantitative PCR assay 
(qPCR). Therefore, the isolated RNA has to be converted to complementary DNA (cDNA) by 
a reverse transcription (RT) reaction before the gene expressions of the samples can be 
measured. 
This cDNA synthesis was performed using the High-Capacity cDNA Reverse 
Transcription Kit from Applied Biosystems (USA). The MultiscribeTM Reverse Transcriptase 
enzyme supplied by the kit converts the RNA to cDNA in the presence of random primers, 
nucleotides (dNTP) and a magnesium containing buffer. The cDNA population produced from 
25 
 
the RT reaction should reflect the original mRNA population both in terms of transcript 
amount and complexity. A detailed protocol for cDNA synthesis is described in appendix A.5. 
 
2.4.2 Quantitative Real time PCR (qPCR) 
The modern qPCR enables quantification of the PCR products in “real time” during 
each PCR cycle. This real time quantification is based on monitoring the fluorescent signal 
emitted as it occurs during the amplification process. Sequence specific or non-specific 
fluorescent dyes may be used for this purpose. 
In this assay, the non-specific fluorescent dye SYBR Green was used as part of the 
KAPA SYBR® FAST Universal 2X qPCR Master Mix (Kapa Biosystems, USA). The SYBR 
Green dye binds to the double stranded helix of DNA produced in the qPCR reaction, and 
quantification of the products is done by measuring the fluorescence after each PCR cycle. 
The time it takes for the fluorescence to reach a defined threshold level, the quantification 
cycle (Cq), and this is used as an estimate for the amount of cDNA for the specific gene in the 
original sample. Gene specific primers were designed using the online Universal Probe 
Library System (Roche Applied Systems, Oslo, Norway) and the primer sequences used are 
listed in appendix A.7. 
cDNA from each sample was diluted 1:10 with double-distilled RNase/DNase free water 
and 5 µL of diluted cDNA sample was pipetted from the stock-plate into 384-well plates in 
quadruplicates using the Bravo Automated Liquid Handling Platform. This plate layout allowed 
us to measure the expression of two genes on all samples (two different genotypes, two different 
days and three different treatments) from one tissue in one run, greatly reducing errors due to run-
to-run variation. All qPCR reactions were done in duplicate. A detailed protocol for the qPCR 
mastermix and settings is described in appendix A.6. 
 
2.5 Statistical analysis 
Statistical analyses were performed using the JMP software v. 11.1.1 and Microsoft 
Office Excel 2010, and p-values < 0.05 were accepted as statistically significant. 
For the ROS generation experiments, the Shapiro-Wilk test was used to evaluate 
whether the data showed a normal distribution and the equality of variance was evaluated 
using the Levene test of homogeneity of variance. If the data were not normally distributed, 
the data were log-transformed before statistical analysis to obtain normally distributed data. 
One-way analysis of variance (ANOVA) was used to analyse the ROS generation 
experiments data. 
Analysis of a possible dose-response relationship was done by a mixed model approach 
using the log-transformed fluorescence intensity as a fixed variable and the experiment date as 
a random variable to minimize the impact of run-to-run variation. 
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Statistical analysis of the RNA yield, purity and integrity for the optimization of the 
homogenization method was carried out by one-way ANOVA or by the non-parametric 
Mann-Whitney U test when the data were not normally distributed. Normal distribution was 
evaluated using the Shapiro-Wilk test. The RNA yield and purity in the main animal study 
was also analysed by one-way ANOVA followed by post hoc Dunnett’s tests to allow for 
multiple comparisons, or by the non-parametric Kruskal Wallis test. ANOVA is thought to be 
a fairly robust method, so even if some of the underlying assumptions (normality and equal 
variances) are not fulfilled, it might still be used with some cautions. 
The gene expression data were analysed using the comparative 2-∆∆Cq method described 
by Livak and Schmittgen (2001). The quantification cycle (Cq) is the fractional cycle number at 
which the fluorescence exceeds a fixed threshold and this was recorded by the SDS v.1.3 software 
during each qPCR run. The raw Cq-values were exported to Microsoft Office Excel, and Cq-
values radically different from other technical replicates were defined as outliers and removed. All 
Cq-values above 35 were considered beyond limit of detection and replaced with 35, as Cq-values 
that are above 35 are generally not reliable (Duale et al., 2012, 2014). The Cq-values of the target 
genes were then normalized against the geometric average of four reference genes identified by 
the BestKeeper software Pfaffl, Tichopad, Prgomet, & Neuvians, 2004). In short the calculations 
of the 2-∆∆Cq method were carried out as follows: 
∆Cq(sample) = Cq(target gene) – Cq(reference gene) 
∆∆Cq = ∆Cq(sample) – Cq(control). 
Fold change = 2-∆∆Cq 
Where the 2-∆∆Cq represents the fold change and the interpretation of data is as follows, if: 
2-∆∆Cq = 1 → No change in gene expression 
2-∆∆Cq > 1 → Induction/increase relative to untreated control 
2-∆∆Cq < 1 → Repression/decrease relative to untreated control 
The distribution of the 2-∆∆Cq values are asymmetric, due to the conversion of an exponential 
process (PCR amplification), therefore the range given in 2-∆∆Cq are also asymmetric (Livak and 
Schmittgen, 2001). This makes it difficult to interpret 2-∆∆Cq values. A value of 2 and 0.5 represent 
the same fold change in different directions. Therefore, the 2-∆∆Cq value was subsequently log2-
transformed in order to make the values symmetrical around zero. For further discussion of the 
need for normalization and selection of reference genes, refer to the discussion, section 4.2.3. 
Statistical analysis of the gene expression data was done by using the one-way ANOVA 
followed by a post hoc Dunnett’s test using the ∆Cq-values to allow for multiple comparisons, 
i.e. comparison between treatment groups.  
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3 Results 
3.1 Cell culture study 
3.1.1 Measurements of ROS-generation after treatment with Ag20- or 
Ag200-particles in mouse embryonic fibroblast cells. 
In this experiment, the main objective was to evaluate whether Ag20- or Ag200-
particles could stimulate ROS generation in MEF cells in vitro. Ogg1+/+ (WT) and Ogg1-/- 
(KO) MEF-cells were treated with different concentrations of Ag20- and Ag200-particles for 
3, 6, and 24 hours (see materials and methods section 2.1.3), and ROS-generation was 
measured by monitoring the fluorescence intensity of the fluorescent dye DCFH-DA. Cells 
treated with different concentrations of hydrogen peroxide (H2O2) were used as positive 
control. 
The experiments showed that there was a higher overall level of ROS-generation in KO 
cells than in the WT cells at most doses at most time points. Although the difference is not 
statistically significant at all measurement points and concentrations, the difference is clearly 
visible from the data shown in figure 3.1.1. There were no statistically significant differences 
in ROS-generation between the different time points, though ROS-generation seems to be at 
similar leves at 3 and 24 hours (figure 3.1.1A and 3.1.1C), but somewhat lower at 6 hours 
(figure 3.1.1B). 
When differences caused by the different treatments were investigated, statistically 
significant increases in ROS generation was found at 24 hours after exposure in KO-cells 
treated with Ag20-concentrations of 20 µg/mL and higher and Ag200-concentrations of 100 
µg/mL and higher. Though the ROS generation at 3 or 6 hours was not significantly increased 
compared with control for either genotype, a tendency of increased ROS was observed in the 
KO cells. The WT cells seem to be far less affected by the treatment than the KO cells, 
judging from the fluorescence levels. 
When investigating the dose-response relationship of ROS-generation after exposure to 
Ag20- or Ag200-particles, a slight correlation was found. Though statistically significant, 
there was only a minor dose-dependent increase in ROS generation. 
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Figure 3.1.1: Generation of ROS at (A) 3 hours, (B) 6 hours and (C) 24 hours for wild type- and knock 
out-MEF-cells. MEF WT cells and MEF KO cells were incubated with DCF-DA for 20 minutes, and ROS-
generation was monitoring by measuring the fluorescence every three minutes for one hour following incubation, 
and the data presented are the mean of the final measurement-cycle, one hour after start of the measurement. 
The values are expressed as mean of four independent experiments with three technical replicates each ± SEM. 
*p < 0.05: Statistically significant versus control. 
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3.1.2 Mitochondrial membrane potential assay after treatment with Ag20- 
or Ag200-particles in mouse embryonic fibroblast cells 
The mitochondrial membrane potential (∆Ψm) is an important parameter of 
mitochondrial function, and may be used as an early apoptosis marker. In order to investigate 
the connection between ROS generation and apoptosis, the JC-1 mitochondrial membrane 
potential assay was performed after 24-hour exposure to Ag20- or Ag200-particles as 
described in section 2.1.2. 24 hour exposure to Ag-particles was chosen based on our ROS-
measurements where we found the highest levels of ROS at this time point, as described in 
section 3.1.1. 
The JC-1 fluorescent dye selectively enters the mitochondria and change colour 
depending on the mitochondrial membrane potential. In healthy cells with high mitochondrial 
membrane potential, the JC-1 dye forms complexes known as J-aggregates that emit a red 
fluorescence, whereas in unhealthy cells with low ∆Ψm, the dye remains in its monomeric 
form, emitting green fluorescence. The ratio between the fluorescence intensity of the J-
aggregates (red) to that of the JC-1 monomers (green) was used as an indicator of cell health 
according to the manufacturer’s protocol, i.e. the lower the ratio, the more cells with a low 
∆Ψm, indicating compromised health. 
 
 
Figure 3.1.2: JC-1 mitochondrial membrane potential assay on MEF-cells treated with Ag20- or Ag200-
particles for 24 hours. J-aggregates are formed in cells with high mitochondrial membrane potential (∆Ψm), 
and JC-1 monomers are formed in cells with low ∆Ψm, i.e. the lower the ratio, the lower average ∆Ψm, and less 
healthy cells. Ratios are presented as mean of four independent experiments with three independent replicates 
each ± SEM. 
0,00
0,50
1,00
1,50
2,00
2,50
3,00
3,50
4,00
4,50
Control 10µg/mL 50µg/mL 200µg/mL 10µg/mL 50µg/mL 200µg/mL 100 µM
Ag20 Ag200 H2O2
J-
a
g
g
re
g
a
te
s 
: 
JC
-1
-m
o
n
o
m
e
rs
 r
a
ti
o
Treatment
JC-1 mitochondrial membrane potential assay
WT
KO
30 
 
The JC-1 mitochondrial membrane potential assay showed no visible trends, other than 
somewhat lower aggregates to monomers-ratio, indicating less healthy cells, in the positive 
control group treated with 100 µM H2O2. As H2O2 was used as a positive control, significant 
difference from control was expected, and the reason for this lack of effect is unclear. It was 
noted that there was very large run-to-run variation in the response. 
 
3.2 Animal study 
Animal studies are expensive, time consuming and complex to conduct. It is therefore 
very important that the tissues obtained from such studies should be used as efficiently as 
possible. The more assays performed per experimental animal, the less in vivo experiments 
are needed. Biologic material obtained from in vivo studies should therefore be regarded as a 
limited and treasured resource, and should be used as efficiently as possible. 
Another important aspect of efficient use of tissue samples in several assays and maybe 
in several different projects is the 3-Rs-principle, which should be met by all animal studies. 
The 3-R’s approach is aimed at maximizing the animal welfare of experimental animals by  
replacing animal studies with non-animal methods whenever possible, refining the post-study 
analysis methodology to obtain the most information possible from the fewest animals 
possible, and refining the animal experiment to remove or minimize potential pain, suffering 
or distress in the experimental animals. 
In this thesis, the main goal was to identify genes that are significantly differentially 
expressed in brain or testis samples from WT and KO treated with Ag20- or Ag200-particles 
in vivo. 
 
3.2.1 Optimization of tissue-homogenization method 
The main goal with optimizing the tissue-homogenization method was to obtain high 
quality and quantity RNA from as little tissue as possible. By using the samples in an efficient 
way, several assays can be performed from the same tissue samples. Prior to isolation of RNA 
from the animal study, a pilot study was performed where RNA was isolated from different 
tissues of two untreated mice to optimize the tissue homogenization method. In order to 
establish a robust tissue-homogenization method, two different methods were evaluated by 
isolating RNA from the tissues and comparing the quantity and quality of the RNA. 
As shown in figure 3.2.1, The RNA yield (RNA µg/mg tissue) obtained from the two 
homogenization methods was similar for brain and lung samples, while a significantly higher 
RNA yield was obtained for UltraTurrax method in liver samples and a significantly higher 
yield was obtained for Precellys method in testis samples. 
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Figure 3.2.1: Comparison of RNA yield from different tissues using two different homogenization 
methods. Sample sizes (n=number of technical replicates): Liver using UltraTurrax (n=10) and Precellys 
(n=12), lung UltraTurrax (n=6) and Precellys (n=4), Testis UltraTurrax (n=6) and Precellys (n=6), Brain 
UltraTurrax (n=8) and Precellys (n=8). RNA yield is presented as average ± SEM. *p < 0.05: Significant 
difference versus the other homogenization method. 
 
The RNA quality consists of RNA purity and integrity. The RNA purity is the absence 
of contaminants (such as proteins, carbohydrates, lipids and salts) and this was measured by 
spectrophotometry as described in materials and methods section 2.3.3.1. As shown in figure 
3.2.2A, similar and comparable average OD 260/280 ratios were observed from both methods.  
An OD260/280-ratio between 1.9 and 2.1 indicates pure RNA and both methods gave an 
average OD260/280-ratio close to 2.  The OD260/280 ratio is an estimate of the purity of the 
type of nucleic acid measured, as different bases absorb light at different wavelengths, DNA 
and RNA will have slightly different OD260/280-ratios. 
However, the average OD 260/230-ratio, which gives an estimate of contaminants such 
as proteins and carbohydrates, was higher for the samples homogenized by Precellys method 
than those homogenized by UltraTurrax method, except for lung tissues (figure 3.2.2B). 
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Figure 3.2.2: Comparison of RNA purity using two different homogenization methods. (A) OD260/280 
ratio of around 2.0 for RNA indicates a pure sample. (B) OD260/230 ratio below 2.0 indicates contaminants. 
Sample sizes (n=number of technical replicates): liver using UltraTurrax (n=10) and Precellys (n=12), lung 
UltraTurrax (n=6) and Precellys (n=4), testis UltraTurrax (n=6) and Precellys (n=6), Brain UltraTurrax (n=8) 
and Precellys (n=8). OD260/280-ratios are presented as mean ± SEM. *p < 0.05 Significant difference versus 
the other homogenization method. 
RNA integrity is another RNA quality parameter and together with RNA purity gives 
the overall RNA quality. The integrity of the RNA samples homogenized using the two 
methods was measured with the Agilent 2100 bioanalyzer (see materials and methods section 
2.3.3.2), and the RNA integrity numbers (RIN) were calculated using the Agilent 2100 Expert 
Software. The software assigns all measured samples a RIN value ranging from 1 to 10, with 
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RIN=1 being the most degraded RNA and RIN=10 being the most intact one. As shown in 
figure 3.2.3, the RIN values observed were similar for both methods in all tissues but liver, 
where it was statistically significantly higher for UltraTurrax. 
 
 
Figure 3.2.3: Comparison of integrity of RNA from different tissues using two different homogenization 
methods. RNA integrity is given as a number between 1 and 10, where 1 is the most degraded RNA profile and 
10 is the most intact (see materials and methods section 2.3.3.2). Sample sizes (n=number of technical 
replicates): liver using UltraTurrax (n=10) and Precellys (n=12), lung UltraTurrax (n=6) and Precellys (n=4), 
testis UltraTurrax (n=6) and Precellys (n=6), Brain UltraTurrax (n=8) and Precellys (n=8). RIN-numbers are 
presented as average ± SEM. 
Overall, based on these data, high-quality RNA could be extracted from both 
homogenization methods. Even though there are some statistically significant differences 
between the two methods, all measurements were within acceptable range for good quality 
RNA. 
From these results, the UltraTurrax homogenization method was selected for the RNA-
isolation procedure for the animal study samples, mainly because the UltraTurrax was the 
cheapest method with low operating cost. The choice of homogenization method is further 
discussed in section 4.2.1. 
All samples, i.e., liver, lung, brain and testis tissues (n=70 samples/tissue, i.e. a total of 
280) from the animal study were homogenized using the UltraTurrax method, and then total 
RNA was extracted from these samples. The RNA quality control was done by 
spectrophotometry to assess the quantity and purity of the isolated RNA and the results are 
presented in appendix D.2. 
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There were differences in RNA yield between the different tissues, and this was 
expected, as cells produce different amounts of mRNA according to function. E.g. the liver 
has a high level of metabolism and therefore is rich in RNA, whereas the more stable 
conditions in the brain requires a lower level of RNA. The isolation of RNA from lung is 
generally viewed as difficult, as the lung tissue is very thin, and therefore is prone to thawing 
and subsequent RNA-degradation during the RNA-isolation procedure. The average OD 
260/280 and OD 260/230-ratio was comparable between the samples (appendix D.2) and the 
ratios were within acceptable range. 
As RNA cannot be used as template in the qPCR reaction, the RNA was copied into 
cDNA by reverse transcription PCR (see materials and methods, section 2.4.1). The cDNA 
yield and purity was measured by spectrophotometry as previously described by measuring 
the OD260/280 and OD260/230 ratios, and all the samples met the criteria for high quality 
cDNA. There were no statistically differences in either of the parameters between genotypes, 
time or treatments. Only cDNA samples from testis and brain were used further in the qPCR 
assay, because it was not possible to analyse all the samples due to time limitations. The 
samples from liver and lung will be analysed by qPCR at the Department in the future. 
 
3.2.2. Gene expression analysis in brain and testis of WT and KO mice 
treated with Ag20- or Ag200-particles 
An investigation of how Ag particle treatments modulated the expression of some 
selected genes involved in inflammation, intercellular signalling, antioxidant defence, 
oxidative stress and DNA damage repair pathways was conducted using the qPCR assay. 
Samples from vehicle treated mice were used as control samples; hence, all other samples 
were compared against the control samples, and the results are shown in figures 3.2.4 – 3.2.9. 
To minimize variation due to technical factors, the data from the qPCR analysis were 
normalized against a set of reference genes. We found that four reference genes met our 
requirements of stability, and these genes are shown in figures D.1 – D.2 in appendix D. 
We did not observe significant genotype differences in gene expression, except for the 
inflammation-related gene Tnf-α. Though the difference in expression of this gene was 
statistically significant, the difference was small. When we sorted genotype differences by 
tissue, we observed significant differences in expression for more genes, particularly in 
antioxidant-related genes in testis and some antioxidant-related genes in brain. There were 
statistically significant differences in expression between the two tissues for all the genes. 
Overall, the effect of the treatments on the gene expression was moderate, with only a 
few genes being close to a ±2-fold difference relative to control. 
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3.2.2.1 Effects of Ag-particles on genes involved in inflammation and intercellular signalling: 
Due to the interconnection of inflammation and oxidative stress, the expression of genes 
involved in inflammation  pathways was investigated. The qPCR data are presented in figure 
3.2.4 for the cytokine-related genes, and in figure 3.2.5 for genes involved in mediating 
inflammation responses through intracellular signalling. 
We observed a statistically significant up-regulation of the Il-1β gene in brains of Ag20-
exposed KO-mice sacrificed at day 1 (figure 3.2.4A). The Il-1β gene encodes for the 
Interleukin beta protein, which is a proinflammatory cytokine produced by activated 
macrophages, as well as neutrophils, epithelial- and endothelial cells.  There were minor 
changes in the expression of some of the other cytokine-related genes, but in brain none of 
these were statistically significant. 
In the testes, there was a statistically significant reduction in the expression of the gene 
Tnf-α in KO mice exposed to Ag20-particles and sacrificed at day 1 (figure 3.2.4B). The Tnf-α 
gene encodes for the cytokine Tumour necrosis factor alpha, which is mainly produced by 
activated macrophages of the immune system to mediate inflammatory response. There was 
also observed a statistically significant, though minor, increase in the expression of Il-1α in 
WT mice treated with Ag200 and sacrificed at day 1. 
For the genes involved in intercellular communication and mediation of inflammatory 
response, there was observed some changes in gene expression between the treatments (figure 
3.2.5). There was a statistically significant increase in the expression of the Cd47-gene in the 
brains of KO-mice treated with Ag20-particles. The expression of Cd200 was found to be 
significantly induced, and expression of Cd200r1 significantly reduced in the brains of WT-
mice treated with both Ag-particles. Though neither are significantly different from control, 
there seems to be opposite regulation of the Cd200r1-gene in WT and KO-mice, with 
decreased expression in brains of WT mice at day 1 following both  Ag-particle treatments, 
and an increase of similar magnitude at the same time and with the same treatments in KO-
mice. 
In summary, both particle types appear to affect the expression of genes involved in 
inflammation and intercellular signalling, primarily at day 1 following exposure. 
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Figure 3.2.4: Gene expression of inflammation-related genes in brain (A) and testis (B). Treatment groups 
are WT day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); WT day 7 control (n=5), Ag20 (n=6), Ag200 (n=5);KO 
day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); KO day 7 control (n=5), Ag20 (n=6), Ag200 (n=5). n=number 
of experimental animals. Values are presented as fold change in 2-∆∆Cq-value ± SEM. *p < 0.05: Statistically 
significant versus control. **p < 0.01: Statistically significant versus control 
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Figure 3.2.5: Gene expression of intercellular signalling-related genes in brain (A) and testis (B). Treatment 
groups are WT day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); WT day 7 control (n=5), Ag20 (n=6), Ag200 
(n=5);KO day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); KO day 7 control (n=5), Ag20 (n=6), Ag200 (n=5). 
n=number of experimental animals. Values are presented as fold change in 2-∆∆Cq-value ± SEM. *p < 0.05: 
Statistically significant versus control. **p < 0.01: Statistically significant versus control 
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3.2.2.2 Effects of Ag-particles on genes related to oxidative stress and antioxidant-defence: 
As the main objective of this thesis was to evaluate oxidative stress as a possible 
mechanism for Ag-particle toxicity, a panel of genes involved in induction of oxidative stress 
and in antioxidant defence pathways were investigated. The qPCR data for the antioxidant 
defence pathway-genes are presented in figure 3.2.6 and 3.2.7, and the data for the NADPH 
oxidase genes, who are involved in ROS formation of immune cells, are presented in figure 
3.2.8. 
In brain, it was observed statistically significant, though small, up-regulation of Sod1 in 
both genotypes at day 1 following exposure to Ag20-particles. There seems to be a slight up-
regulation of the genes Sod3 and Cat in the brains of both genotypes at day 1 following 
exposure to Ag20-particles.At day 7, Sod3 and Cat were statistically significantly up-
regulated in both genotypes after treatment with Ag200-particles. Sod3 encodes for the 
superoxide dismutase enzyme, which is responsible for the detoxification of superoxide 
radicals into hydrogen peroxide, and the Cat-gene encodes for the catalase-enzyme which is 
responsible for the further decomposition of H2O2 into water and oxygen (see the introduction 
chapter, section 1.3.2 and figure 1.3.1). It should be noted that although statistically 
significant, the expressions of all antioxidant related genes in figure 3.2.6A are small, with 
less than 1-fold increase relative to control. It was further observed that expression of Gpx2 
was significantly increased at day 7 in the brains of WT mice treated with Ag20, and that 
expression of Nrf2 was significantly decreased at day 1 in KO mice treated with Ag200 
(figure 3.2.7A). 
In testes, we observed fewer significant responses to the treatment, than we did in brain. 
Expression of Gpx2 was significantly reduced at day 7 in the testes of KO mice exposed to 
Ag20-particles (figure 3.2.7B). Other than that, there are few notable changes in the 
expression of antioxidant-related genes in testis. As with the gene expression in brain, the 
differences in expression are generally low, especially for the genes presented in figure 3.2.6. 
Our study investigated the potential changes in the expression of genes involved in the 
NADPH oxidase complex, as this complex is known to produce ROS as a part of the immune 
response towards pathogens (Sankarapandi, et al., 1998). In the brains of KO-mice, we 
observed statistically significant up-regulation of all three of the investigated genes at day 1 
following treatment with Ag20-particles. At day 7, the expressions of these genes in KO are at 
similar levels as that of the control. Though not statistically significant, there seems to be a 
slight increase of the expression of all the investigated genes in WT at day 7 following 
exposure to both particle types. We also noted a rather large variance in the data for WT brain 
at day 7. 
We did not observe statistically significant changes in the expression of NADPH 
oxidase related genes in testis. There are some possibly interesting trends showing a slightly 
increased expression of Nox4 and Noxo1 in WT after exposure to both particle types, similar 
to what we see in brain, but there is also large variation in the data, as seen by the standard 
error of the mean (figure 3.2.8). 
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Figure 3.2.6: Gene expression of antioxidant-related genes (I) in brain (A) and testis (B). Treatment groups 
are WT day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); WT day 7 control (n=5), Ag20 (n=6), Ag200 (n=5);KO 
day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); KO day 7 control (n=5), Ag20 (n=6), Ag200 (n=5). n=number 
of experimental animals. Values are presented as fold change in 2-∆∆Cq-value ± SEM. *p < 0.05: Statistically 
significant versus control. **p < 0.01: Statistically significant versus control 
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Figure 3.2.7: Gene expression of antioxidant-related genes (II) in brain (A) and testis (B). Treatment groups 
are WT day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); WT day 7 control (n=5), Ag20 (n=6), Ag200 (n=5);KO 
day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); KO day 7 control (n=5), Ag20 (n=6), Ag200 (n=5). n=number 
of experimental animals. Values are presented as fold change in 2-∆∆Cq-value ± SEM. *p < 0.05: Statistically 
significant versus control. **p < 0.01: Statistically significant versus control 
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Figure 3.2.8: Gene expression of oxidative stress-related genes in brain (A) and testis (B). Treatment groups 
are WT day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); WT day 7 control (n=5), Ag20 (n=6), Ag200 (n=5);KO 
day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); KO day 7 control (n=5), Ag20 (n=6), Ag200 (n=5). n=number 
of experimental animals. Values are presented as fold change in 2-∆∆Cq-value ± SEM. *Statistically significant 
versus control (p < 0.05). **Statistically significant versus control (p < 0.01) 
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3.2.2.3 Effects of Ag-particles on genes related to DNA repair: 
ROS generation is linked to a range of cellular damage, including damage to the DNA. 
Previous studies have showed that Ag-particles cause DNA strand breaks, and it is possible 
that this damage occurs as a result of oxidative DNA damage. We investigated the expression 
of a panel of four genes involved in the DNA damage repair pathway, all involved in the 
removal of the 8-OxoG lesion, and the results are shown in figure 3.2.9.  
Our experiment showed a significantly decreased expression of Neil2 at day 1 in the 
brains of KO mice exposed to either types of Ag-particles. The decreased expression of Neil2 
after treatment with Ag200 was, however, low, and therefore should be interpreted with 
caution. We also observed statistically significant decrease in the expression of Apex1 in 
brains of WT mice exposed to Ag200, though the difference in expression relative to control 
was low for this gene as well 
In the testis of exposed animals, we observed no statistically significant differences in 
expression of DNA damage repair related genes in response to any of the treatments. The 
genes Neil1, Neil2 and Neil3 might be slightly induced in WT mice at day 7, but the results 
are not statistically significant, and the variation in the data is large. 
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Figure 3.2.9: Gene expression of DNA repair-related genes in brain (A) and testis (B). Treatment groups are 
WT day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); WT day 7 control (n=5), Ag20 (n=6), Ag200 (n=5);KO day 
1 control (n=6), Ag20 (n=6), Ag200 (n=6); KO day 7 control (n=5), Ag20 (n=6), Ag200 (n=5). n=number of 
experimental animals. Values are presented as fold change in 2-∆∆Cq-value ± SEM. *p < 0.05: Statistically 
significant versus control. **p < 0.01: Statistically significant versus control 
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4 Discussion 
ROS are present in all cells and are produced by mitochondria and in cytoplasmic 
oxidation processes. ROS may be harmful to the organism, but on the other hand, they also 
act as messengers in a variety of cellular processes. Under environmental stress the cell will 
increase ROS generation, and this increase can pose a threat to cells by causing peroxidation 
of lipids, oxidation of proteins, and damage to nucleic acids, enzyme inhibition and cell death 
(Sharma et al., 2012). Unrepaired oxidative damage may eventually cause adverse health 
effects like cancer in humans. There are several reports on the Ag-particle-mediated ROS 
generation (Foldbjerg, et al., 2011;  Lee, et al., 2014;  Li et al., 2003), and the mitochondria 
have been found to be a sensitive target for Ag particle toxicity (Hussain, et al., 2005;  Piao, et 
al., 2011). 
The induction of ROS generation and possible effects of the mitochondrial membrane 
was investigated following in vitro exposure to Ag-particles in MEF cells. Most toxicity data 
of Ag-particles are in vitro data, and in vivo data are still scarce. This thesis builds on a 
previous mice experiment in our lab, where oxidative stress in testis, liver and lung after Ag-
particle exposure was investigated (Asare, et al., 2014). In order to get a deeper understanding 
of Ag-particles induction of oxidative stress, we examined the expression levels of a panel of 
22 selected genes involved in the processes of oxidative stress, antioxidant defence, 
intercellular signalling, inflammation and DNA damage repair in tissues from brain and testis 
by qPCR assay. This experiment was correlated with a mechanistic in vitro experiment. 
4.1 Cell culture study 
In vitro systems cannot exactly replicate the complex interactions that happen in an 
intact organism in vivo, but they can provide important mechanistic information about the 
effect of a compound on biological systems. In vitro studies are valuable as mechanistic 
support for in vivo studies. 
The MEF cell lines (wild type- (Ogg1+/+) and knockout- (Ogg1-/-)) used in this study 
were isolated from mouse embryos, and then the cells were immortalized.  Immortalized MEF 
cells are commonly used in toxicological studies (e.g. Ahamed, et al., 2008;  Lee, et al., 
2014). As MEF cell lines can be generated from genetically manipulated mouse embryos, 
these cell lines can be a powerful tool to investigate molecular mechanisms for toxicity. As 
we wanted to investigate the effects of impaired repair of oxidative DNA damage on Ag-
particle induced ROS generation, MEF cells were ideal. However, there are some issues when 
extrapolating findings from in vitro cell line experiments to humans. Particularly when the 
cells are immortalized using viral transformation and they were established from other 
species, and the findings must thus be interpreted with caution. MEF cells were selected to 
resemble the KO mice used in the animal study. In this way, it would be easier to relate our 
findings in vitro cell culture study with the in vivo data. 
Nanoparticles are known to interfere with most of toxicity assays in in vitro, making the 
interpretation of the results difficult (Kroll et al., 2012;  Ong et al., 2014). Sabatini et al. 
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(2007) showed that silver NPs interacted directly with fluorescent dyes and quenched their 
signals, presumably by binding to their surface. Ong, et al. (2014), examined the interference 
of four different nanoparticles on six different in vitro toxicity assays, and found that each 
nanoparticle interfered with at least one of these assays. Even though there are no reports on 
the interference of Ag-particles on the performance of the exact assays used in this thesis, it is 
reasonable to assume that Ag-particles may interfere with these assays. 
 
4.1.1 Measurements of ROS-generation in MEF-cells 
The investigation of ROS-generation in the MEF (WT and KO) cell lines after treatment 
with Ag20- and Ag200-particles using the fluorescent probe DCFH-DA, showed that a 
statistically significantly higher level of ROS-generation in the KO cells with all the different 
treatment groups, including the control group, compared with the effects observed in the WT-
cells following the treatments (figure 3.1.1). The reason for the higher ROS level in the KO-
cells upon the treatments is unclear. One explanation can be that the lack of the Ogg1 gene 
may lead to high background level of ROS. Bacsi et al. (2007) and co-workers have reported 
that an increased background level of ROS in a subset of the MEF KO cell lines compared 
with WT cells, and as the MEF cells they used are established by the same procedure as the 
cells used in our experiment (Klungland et al., 1999), it is likely that our MEF cells retain 
similar characteristics. 
Although the KO MEF cells showed an increased background level of ROS, there is 
still a clear Ag-particles mediated dose-dependent increase in the ROS levels. Our results are 
in agreement with previous studies of Ag-particles and ROS generation in vitro 
(Bartlomiejczyk et al., 2013). Foldbjerg, et al. (2011) observed significantly increased levels 
of ROS 24 hours after the treatment of the human alveolar cell line, A549, with 78 nm AgNPs 
at concentrations ranging from 2.5 to 15 µg/mL. 
Lee, et al. (2014) studied ROS-generation in the NIH 3T3 mouse embryonic fibroblast 
cell-line after exposure to Ag-particles also using the DCFH-DA-assay, and found that ROS 
levels were significantly increased after 3 and 6 hours following exposure to 15 mg/ml 
AgNPs. Piao, et al. (2011) found that AgNPs induce increased ROS-generation at 0.5, 1, 3, 6 
and 12 hours after exposure of Human Chang liver cells to concentrations of 4 µg/mL. In light 
of these results, we would have expected significant increases in ROS generation at 3 and 6 
hours as well as at 24 hours. 
We observed a high inter-run variation in our results, and this may to some degree have 
masked our results, and could have been avoided by using some form of inter run control 
(IRC). In addition, the DCFH-DA-assay is known to be interfered with by NPs, especially at 
higher concentrations. Kroll, et al. (2012) investigated the effect of 24 different engineered 
nanoparticles on the DCF-assay, and found that all nanoparticle types interfered with the 
assay by reducing detection of DCF fluorescence at concentrations of 32 µg/ml and above. 
This is therefore a possible explanation of the lack of significant increases in ROS generation. 
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4.1.2. Mitochondrial membrane potential assay 
The possible effects on the mitochondrial membrane potential of WT and KO MEF cells 
after 24 hours of Ag-particle exposure (figure 3.1.2) showed no clear response to any of the 
treatments, except a slight decrease in the positive controls treated with H2O2. 
As previously noted, nanoparticle interference has been shown in many in vitro toxicity 
assays, and it is a possible explanation for the lack of clear response in our study. As the kit 
protocol did not include immediate removal of the particles before centrifuging the plate, it is 
likely that most of the particles were still in the plate at the time of measurement. Even with 
interference of Ag-particles, this cannot explain the lack of responses in the positive control 
group treated with H2O2. The reason for this is still unknown and due to the high cost of the 
kits used and the time-frame of my thesis, the experiment was not repeated. The only other 
studies that to our knowledge have reported using the JC-1 assay after treatment with Ag-
particles have only used the JC-1 assay for confocal imaging (Stensberg et al., 2014), or have 
failed to report their results from their flow-cytometric fluorescence assessment (Piao, et al., 
2011). 
 
4.2 Animal study 
4.2.1 Optimal homogenization method 
High quality RNA is a prerequisite for gene expression profiling studies (e.g. qPCR or 
microarray), and obtaining good quality RNA was one of the main goals of this thesis. Two 
tissue homogenization methods performance were evaluated in regards to RNA yield, purity 
and integrity (figures 3.2.1 – 3.2.3).  From this method comparison, a high quality RNA with 
sufficient RNA amount was obtained from both homogenization methods. However, the 
UltraTurrax method was selected due to slightly better results in the RNA integrity test, as 
well as it being the most cost- and time-efficient method of the two.  In addition, UltraTurrax 
was the method was used for isolation of the RNA samples from liver, lung and testes of mice 
sacrificed at day 7 of the experiment, which was performed prior to this thesis. 
 
4.2.2 Gene expression analysis by qPCR assay 
In this thesis, the transcriptional response of a panel of 22 genes based on their role in 
oxidative stress, antioxidant defence, intercellular signalling, inflammation and DNA damage 
repair, following exposure of WT and KO mice with Ag-particles was evaluated by qPCR 
assay. Samples from vehicle treated mice were used as control samples; hence, all other 
samples were compared to the control samples. There are few studies examining the effects of 
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exposure to Ag-particles on gene expression pattern of mice, and the data available in the 
literature for direct comparison is scarce. It is therefore difficult to discuss the findings. 
Nevertheless, a number of variables must be controlled and reduced to minimal levels in 
order to obtain a reliable and reproducible gene expression results. These variables include, 
the amount of starting material, enzyme efficiencies, tissue differences, sample handling and 
individual differences, which all may affect the qPCR assay, and hence may lead to 
misinterpretation of the results. It is therefore very important to remove pre- or post-analytical 
systematic biases caused by technical rather than biological sources from the qPCR data. The 
effects of this “noise” can be removed from the data using good normalization strategies, 
while still maintaining the ability to detect significantly differentially expressed genes. There 
are several ways to remove technical biases and using reference genes are considered a gold 
standard for normalization of qPCR data. A good reference gene should have a constant level 
of expression independent of experimental treatments. The stability of a total of six potential 
reference genes selected based on literature (Huggett et al., 2005) and previous experience in 
our lab were evaluated. The expression level of four of the six examined reference genes was 
relatively stable across both treatment and tissue groups and the results are presented in 
appendix D (figure D.1 and D.2). The geometrical average of the four reference genes were 
used to normalize the qPCR data employing the comparative ∆∆Cq-method (Livak and 
Schmittgen, 2001) and it is a recommended normalization strategy (Vandesompele et al., 
2002). 
We did not observe significant genotype differences in gene expression, except for the 
inflammation-related gene Tnf-α. Though the difference in gene expression was statistically 
significant, the difference was small. When we took both genotype and tissue into 
consideration, we observed significant differences in expression for more genes, particularly 
in antioxidant-genes in testis and some antioxidant-genes in brain. There were, as expected, 
significant differences in expression between the two tissues for all the genes. 
In general, the gene expression analysis showed only a limited to moderate response to 
the treatments; only the transcript levels of a few of genes were close to the ±2-fold change, 
with no genotype- specific pattern.  Notably the gene expression in testis showed limited 
response for all treatments (figures. 3.2.4B – 3.2.9B). 
 
4.2.2.1 Effects on genes involved in inflammation and intercellular signalling 
One of the greatest concerns in Ag-particle induced toxicity is oxidative stress as 
previously described in the introduction (section 1.3). Inflammation is closely linked to 
oxidative stress, and hence is an important mechanism to address in this thesis. It has been 
shown that pro-inflammatory cytokines enhance expression and activation of NADPH 
oxidases (Nox) that result in free radicals generation and oxidative stress (Mander, et al., 
2006;  Mo, et al., 2009). Based on in vitro studies inflammation is a suggested mechanism of 
silver nanoparticles toxicity (Bartlomiejczyk, et al., 2013). However, there have only been a 
few in vivo studies investigating inflammation in relation to Ag-particle exposure. 
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The Ag-particles gave some effects on the inflammation-related genes, however, the 
magnitude of the expression levels were not high. Il-1β was statistically significantly up-
regulated in KO brain following exposure to AgNPs. In testis, Tnf-α was significantly down-
regulated in the KO mice following exposure to nanoparticles, whereas Il-1α was up-
regulated in WT after exposure to Ag200-particles. However, the increase of Il-1α is so small 
it should be regarded as on the borderline of significance and it’s biological significance 
should be interpreted with caution. Previous experiments in our lab showed that Ag-particles 
induced apoptosis and necrosis time- and dose-dependently in primary testicular cells form 
WT and KO (Ogg1-/-) C56BL6 mice, and in human embryo tumour cell line NT2 (Asare, et 
al., 2012). Necrotic cells could stimulate to inflammation which could be enhanced by 
proinflammatory cytokines. Whether necrosis occurs in vivo as well in vitro after Ag-particle 
exposure is difficult to predict. 
The genes Cd47, Cd200 and Cd200r1 (figure 3.2.5) all encode for proteins with 
important functions in intercellular signalling and inflammation, and we found all of these 
genes to be modulated by exposure to Ag-particles. 
Cd47 was significantly induced in the brains of KO mice at day 1 in the group treated 
with Ag20-particles. Cd47 modulates cell motility, leukocyte adhesion and migration, 
phagocytosis, and activation of platelets (Brown and Frazier, 2001;  Parkos et al., 1996), and 
has been shown to trigger cell death in a wide range of cell types, including activated T-cells, 
monocytes and dendritic cells (Johansson et al., 2004). Xing et al. (2009) observed that 
activation of Cd47 elevated levels of active caspase 3, a protease central in apoptosis, and 
increased the generation of reactive oxygen species (ROS) in a time-dependent manner. Our 
results may suggest that Cd47 is involved in the toxicity of Ag-particles. To our knowledge, 
there have been no other studies investigating the expression of Cd47 after treatment with Ag-
particles, and this makes our findings difficult to interpret. 
A moderate increase in the expression of Cd200 was observed in the brains of WT mice 
at day 1 with both Ag-particles. Cd200 (in earlier studies referred to as OX2) is expressed in a 
wide variety of cell types including neurons and endothelial cells in the central nervous 
system (CNS) (Wright et al., 2001), whereas it’s receptor, Cd200r1, is predominantly 
restricted to cells of myeloid origin, such as macrophages and microglia (Wright et al., 2003). 
Binding of the Cd200 ligand to the Cd200 and Cd200r1 receptor present on the surface of 
myeloid cells, have been shown to limit inflammation by decreasing macrophage activity 
(Hoek et al., 2000;  Walker and Lue, 2013). The expression of the Cd200r1 receptor seems to 
be genotype dependent, with down-regulation in WT cells and up-regulation in KO cells at 
day 1 following exposure to both particle types. The increased expression of Cd200 suggests 
activation of this anti-inflammatory system. However, as the regulation of the receptor and its 
ligand will vary during the course of the inflammatory response, the information from just one 
time point is difficult to interpret. 
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4.2.2.3 Effects on genes related to oxidative stress and antioxidant-defence 
Generation of ROS and induction of oxidative stress has long been the primary 
hypothesis of Ag-particle toxicity (Bartlomiejczyk, et al., 2013;  Foldbjerg, et al., 2011), but 
only a few studies have investigated this in vivo. Rahman et al. (2009) investigated the 
expression of a large panel of genes related to oxidative stress in mouse brains 24 hours after 
a single intraperitoneal injection with Ag-particles of 25 nm. This study has however been 
criticized for using doses that are all excessively high (100, 500 and 1000 mg/kg bw), and 
may therefore lack relevance to human exposure (Johnston, et al., 2010). 
In this thesis, we observed that Ag-particles affected the expression of several genes 
linked to oxidative stress and antioxidant defence, primarily in brain. Of particular interest is 
the increased expressions of the antioxidant enzyme genes Sod1, Sod3, Cat  which were 
visible in the brains of both genotypes at day 1 following exposure to Ag20 particles, and at 
day 7 following exposure to Ag200 particles in both genotypes (figure 3.2.6A),. These results 
should be interpreted with a great deal of caution, as the differences from control, although 
statistically significant, are small. However, the results are still interesting, as the pattern is 
spanning several genes, and occurs in brains from both genotypes. To our knowledge, this is 
the first time Ag-particle mediated changes in the gene expression of brain have been shown 
to occur at moderate doses. A possible explanation for the response to Ag20-particles at day 1 
and to Ag200-particles at day 7 may be the decreased rate of excretion of the larger particles 
as shown by Dziendzikowska, et al. (2012). 
Another interesting cluster of gene responses is the increased expression of NADPH 
oxidase-genes at day 1 in KO-mice exposed to Ag20-particles (see fig. 3.2.8). NADPH 
oxidases are found in neutrophil granulocytes of the immune system, where they generate 
superoxide to combat pathogens. An increase in the expression of these genes may suggest 
that immune cells target the AgNPs as pathogens and attempts to destroy by generating ROS. 
This induction of NADPH oxidases and antioxidant-related genes in brain is in agreement 
with previous studies of the role of NADPH oxidases in damage caused by ultrafine particles 
(Mo, et al., 2009). This indicates that ROS generated by the NADPH oxidase complex as a 
response to Ag-particles may be a possible mechanism of toxicity. 
The gene expression of the testes seems to be less affected by the Ag particle treatment, 
with no statistically significant effects on genes related to oxidative stress and antioxidant 
defence, other than a reduced expression of Gpx2 at day 7 in KO mice exposed to Ag20-
particles. There is also possibly a slight increase in the expression of NADPH oxidase 
complex-related genes at day 7 following exposure to both Ag20 and Ag200 in the WT mice. 
The reason for the reduced effects of Ag-particles on the gene expression in testis as opposed 
to brain is unclear. 
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4.2.2.4 Effects on genes involved in DNA damage repair 
Approximately 240,000 spontaneous DNA lesions occur daily in each mammalian cell 
(Billen, 1990). Environmental stress, such as exposure to Ag-particles, may add to the burden, 
and may also introduce more complex damages that might lead to an overload of the repair 
mechanisms. Unrepaired DNA damage may result in cell death, and more importantly can 
cause mutagenesis and carcinogenesis, and it is therefore crucial for the cell to be able to 
repair DNA efficiently. In this work we examined expression of important genes in the BER 
repair pathway Apex1, Neil1, Neil2 and Neil3. BER is the major pathway to repair single 
strand breaks and remove base lesions and are initiated by a DNA glycosylase (e.g. Ogg1) 
which recognize and excises the damaged base (e.g. 8-oxoG) (Krokan, et al., 2000).  As the 
Ogg1 enzyme is important for the primary mechanism for removal of oxidative DNA lesions, 
we expected an increase in the expression of the examined DNA damage repair related genes 
in the KO mice. 
Our results show only a limited effect of Ag-particle exposure on the expression of 
genes related to DNA damage repair in both brain and testis. We observed a significantly 
decreased expression of the Neil2 gene, which is thought to be one possible back-up 
mechanism for repair of 8-OxoG-lesions (Katafuchi, et al., 2004), at day 1 in brains of KO-
mice. We also observed a slight induction of Neil1 in brains of KO mice at day 1. In testis, we 
found no statistically significant effects on expression of DNA damage repair-related genes. 
Previous studies in our lab have shown that exposure to Ag-particles cause DNA strand 
breaks both in vitro (Asare, et al., 2012) and in vivo (Asare, et al., 2014), and an increased 
expression of DNA damage repair associated genes would therefore be expected, especially in 
the KO mice. A possible explanation for the lack of induction of the alternative DNA damage 
repair pathways is that the pathways studied are supplemented by other mechanisms. 
Nucleotide excision repair (NER) has been suggested to be another backup mechanism for the 
DNA damage repair normally conducted by BER (Lin and Sancar, 1989;  Sunesen et al., 
2002). 
 
4.2.3: Relevance of findings in a regulatory- and human health perspective 
Even if ROS generation is a suggested mechanism of Ag-particle toxicity, studies have 
examined ROS generation caused by Ag-particles in vivo. Generation of ROS and induction 
of oxidative stress is associated with pathogenic mechanisms of a long list of diseases, 
including atherosclerosis, neurodegenerative diseases such as Alzheimer's and Parkinson's 
disease, cancer, inflammatory diseases, diabetes mellitus, as well as infertility and aging 
(Agarwal et al., 2014;  Durackova, 2010;  Mittal et al., 2014).  
This thesis has focused mainly on the possible effects of Ag-particle exposure on gene 
expression in brain and testis, as both neurodegenerative diseases and male infertility are 
associated with oxidative stress, and as such, Ag-particle exposure may contribute to this. In 
particular, concern has been voiced over the possible neurotoxic effects of Ag-particles 
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(Sharma and Sharma, 2012), where some studies have suggested that exposure to Ag-particles 
may directly induce learning- and memory deficits in rats (Liu, et al., 2012). The ability of 
Ag-particles to trigger oxidative stress and inflammation in the CNS have also been suggested 
to increase the risk of developing neurodegenerative diseases such as Parkinson’s disease 
(Lucchini et al., 2012;  Myhre, et al., 2013). However, further research into the mechanisms 
of Ag-particle toxicity is required to establish this link.  
Male fertility problems affects about 7.5 % of all couples trying to conceive, and 
oxidative stress is noted as one of several mediators of male infertility (Agarwal, et al., 2014). 
In addition, it has been shown that Ag-particles directly affect both spermatogonia and Leydig 
cells of the testis (Ema, et al., 2010;  Garcia et al., 2014). The genotoxic abilities of Ag-
particles should also be of concern for reproductive toxicity, as in addition to possible 
mutagenesis or carcinogenesis, mutations in germ cells may be passed on causing 
dysfunctions in the next generation (Skinner, 2014). Concern regarding the increasing use of 
Ag-particles is therefore well-founded, and risk assessment strategies are needed. 
As there are relatively few well-conducted in vivo experiments suitable for risk 
assessment of Ag-particles, more in vivo data in this area is needed. Mechanistic studies as 
presented in this thesis are used as support for mode of action of compounds in risk 
assessment. This needs to be backed up by more functional assays. In this thesis we 
investigated changes in gene expression following exposure to Ag-particles in vivo, and our 
findings would benefit from further analysis of protein expression (e.g. Western blotting) to 
investigate the effects at a physiologic level. Our findings contribute with novel mechanistic 
understanding of Ag-particle toxicity in vivo.  
 
4.3 Conclusions 
In this thesis, we have found that Ag-particles induce generation of reactive oxygen 
species in vitro. We were not able to determine whether Ag-particle exposure affects the 
mitochondrial membrane potential, possibly due to interference from the particles themselves 
on the assay. Our observations of increased ROS generation in vitro are supported by the gene 
expression results, which showed significant, but moderate, changes in the expression levels 
of genes related to oxidative stress and antioxidant defence. In particular, the small increase in 
expression of antioxidant enzyme-genes and the up-regulation of the ROS producing NADPH 
oxidase genes, and the Cd47 gene in brains of KO mice are interesting.  
Overall, the gene expression result shows some effects upon Ag-particle exposure, 
however, the changes in the expression level were moderate. Further, our results indicate that 
ROS generation and induction of oxidative stress, possibly through the NADPH oxidase or 
the Cd47 pathways, is a plausible mechanism of Ag-particle toxicity. Long-term animal 
studies may be needed to get more insight in Ag-particles ability to induce chronic 
inflammation. 
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4.4 Future work 
An immediate follow-up of this study should analyse the cDNA from liver and lung by qPCR 
assay and investigate changes in the gene expression. An alternative assay for apoptosis such 
as PI/Hoechst or the Annexin V assay could be used to investigate at which concentrations the 
Ag-particles used in this study causes cell death in MEF cells. Along with an investigation of 
the gene expression of MEF cells exposed to similar concentrations of Ag-particles that we 
have shown to cause ROS generation results from these studies would be a good way to relate 
the in vitro results to the effects on gene expression seen in vivo. Supporting the gene 
expression data with data on protein expression using Western blotting may be performed to 
link the changes in gene expression to a physiologic response. 
Further insight in how nanoparticles interfere with common in vitro toxicity assays is vital for 
future studies of the mechanisms of nanoparticle toxicity. 
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Appendix A: Detailed protocols 
A.1 Cell maintenance 
A.1.1 Passaging 
After seeding, the cells enter a lag period followed by a period of exponential growth. When 
seeding approximately 1 million cells/75 cm2 for the KO cells and 500 000 cells/75 cm2 for 
the WT cells, the MEF cultures reached a confluence of approximately 80% three to four days 
after seeding. 
Procedure 
All work where the cell flask was open was done under sterile conditions under laminar flow. 
All equipment used was sterilized with 70 % ethanol before entering the laminar flow bench. 
a) Trypsin (0.05 % trypsin, 0.1 mM etylenediaminetetraacetic acid (EDTA)), phosphate 
buffered saline without calcium and magnesium (PBS) and growth medium was preheated to 
37 °C in the cell cultivator. 
b) The growth medium (15 mL) in the culture flasks was removed and the cells washed 
gently twice with 15 mL of PBS to remove remains of growth medium, as foetal calf serum in 
the medium inhibits trypsin. 
c) 2 mL of trypsin was added to the cells, whereof 1 mL was instantly removed. The cells 
were incubated with the remaining 1 mL of trypsin at 37 °C for 3 min. 
d) After incubation, the cells were inspected under microscope to verify that the 
trypsination was successful. This can be visually seen by observing rounding of the cells. 
e) The cells were unfastened from the bottom of the flaks by gently tapping the sides of 
the flask. 
f) The trypsin was inactivated and the cells harvested by flushing the bottom of the flask 
with 4 mL of growth medium. The process was repeated with another 5 mL of medium to 
ensure that all cells were harvested. The harvested cells were stored on ice until seeding. 
g) Cells were counted using a Bürker-chamber. 
h) After counting, the cells were resuspended in the growth medium and 1 mL of the cell 
suspension was added to a 75 cm2 flask along with 14 mL of growth medium. 
 
A.1.2 Cell counting 
Cell concentration (number of cells/mL) was determined by counting in a Bürker-chamber. 
100 µL cell suspension was mixed with 100 µL Trypan blue. Trypan blue is a dye that does 
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not traverse membranes of healthy cells. As the dye passes the membranes of dead or 
damaged cells, these will appear with a distinctive blue colour under a microscope. 
A Bürker counting chamber is a thick glass microscope slide with a rectangular indentation 
that creates a chamber. The chamber holds 10 µL, and an imprinted grid on the chamber 
surface allows for an easy counting of cells in this volume: 
The grid is divided into 9 large squares, and each square is bounded by a triple set of lines. 
The centre line of these is the edge of the counting area, and all living and dead cells within 
the central lines of a large square were counted, also those which touched the lower and left 
border, but not those which touch the lower and left borders. 5 out of the 9 squares were 
counted. 
 
A.1.3 Thawing of cells 
a) The cells were defrosted under running water for approximately 2 min, after which 
cell line and passage number was noted. 
b) The cells were transferred to a 15 mL tube containing 13 mL growth medium, 
preheated to 37 °C. This tube was centrifuged at 200 x g at 8 °C for 5 min. 
c) The supernatant was discarded, and the cells were resuspended in 15 mL of preheated 
growth medium. The cell suspension was seeded in a 75 cm2 cell culture flask. 
 
 
A.2 RNA isolation 
Procedure 
a) The lysate was filtered through a filtration column to remove cellular debris, pieces of 
insufficiently homogenized tissue and shear DNA. The lysate was centrifuged at 14100 g for 
15 sec. As the column has a capacity of 700 uL, the process was repeated if the lysate volume 
was greater. 
b) Binding of RNA to the binding column was facilitated by adding 500 uL of 70 % 
ethanol to the filtered lysate. 
c) Lysate/ethanol-mix was pipetted into binding columns and centrifuged at 14100 g 
(max speed) for 15 sec, and the flow-through liquid discarded. The procedure was repeated 
until all the lysate had been spun through the binding column. 
d) 500 uL of wash solution 1 was added to the binding column and spun at 14100 g for 
15 sec. After this step the binding column was transferred to a fresh 2 mL tube. 
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e) 500 uL of wash solution 2 was added to the binding column and spun at 14100 g for 
15 sec. The process was then repeated for a third column wash. After the second wash, the 
columns were centrifuged for 2 min at maximum speed to dry the columns of ethanol. This 
drying-step is given as an optional step in the procedure following the kit. 
f) The binding column was then transferred to a fresh 2 mL tube and 50 uL of Elution 
solution was pipetted directly onto the filter, covering the entire filter area. The samples were 
centrifuged at maximum speed for 1 minute. 
 
A.3 Nanodrop spectrophotometer 
a) The system was initiated with a sample of 1.5 µl distilled water. 
b) “RNA-40” was chosen for RNA samples and “other-39” for cDNA samples. 
c) A blank measurement was conducted using 1.5 µl elution solution from the GenElute 
Mammalian Total RNA Miniprep Kit for RNA and RNase-free water for cDNA. 
d) 1.5 µl of the sample was pipetted onto the pedestal. 
e) The system measured the absorbance of the sample giving the concentration in ng/µl, as well as 
A260/280- and A260/230-ratios. 
f) The retention system was cleaned with a distilled water sample. 
 
A.4 Protocol for the RNA Nano 6000 Assay for RIN determination 
The RNA 6000 gel was prepared according to the manufacturer’s instructions: 
a) The reagents were allowed to equilibrate to room temperature for 30 minutes before 
use, after which 550µL of RNA 6000 Nano gel matrix was spun down through a spin 
filter at 1500 g for 10 minutes. 
b) The filtered gel was divided in aliquots of 65 µL and stored at 4 °C. 
The gel-dye mix was then prepared: 
a) Room-tempered dye concentrate was vortexed for 10 seconds and spun down, after 
which 1 µl of the RNA 6000 Nano dye concentrate was added to a 65 µL aliquot of 
RNA 6000 Nano gel. 
b) The gel-dye mix was thoroughly vortexed and stored at 4 °C in the dark, to be used 
within one day. 
c) The gel-dye mix was spun down for 10 minutes at room temperature at 13000 g. 
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The gel-dye mix was loaded onto a RNA Nano chip: 
a) 9.0 µL of gel-dye mix was added to the bottom of well marked G 
b) The gel-dye mix was pressurized using the syringe supplied with the kit. After 30 
seconds of pressurizing, the plunger was released. 
c) 9.0 µL of the gel-dye mix was added to the two top-left wells of the chip. 
After loading the gel-dye mix, the samples were added to the chip: 
a) An aliquot of the supplied ladder was thawed on ice, and 1 µL was added to the well 
marked with a ladder-symbol. 
b) The RNA-samples were heat denatured at 70°C for 2 minutes before loading them on 
the chip.1 µL of each sample was pipetted into each of the 12 sample wells. 
c) The chip was then vortexed using the IKA vortex mixer at 2400 rpm for 60 seconds. 
d) The prepared chip was inserted in the Agilent 2100 bioanalyzer and the run was 
started within 5 minutes. 
 
A.5 Protocol for cDNA synthesis 
Protocol: 
a) Isolated RNA was thawed on ice, transferred to 96-well reaction plates and diluted with 
ddH2O to give a concentration of 100 ng/µL in all of the samples. In samples where there 
were insufficient RNA to obtain this concentration, the samples were diluted 1:1 with ddH2O 
in order to prevent buffers etc. used in RNA-isolation to interfere with cDNA synthesis. The 
remaining RNA was stored at -80°C. 
Component Volume per reaction (µL) 
10X RT Buffer 2,0 
25X dNTP Mix 0,8 
10X RT Random Primers 2,0 
MultiScribeTM Reverse Transcriptase 1,0 
Nuclease-free H2O 4,2 
Total volume per reaction 10,0 
Table A.5.1: RT-PCR Mastermix. 
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b) After dilution, 10 µL of each sample was transferred to another 96-well reaction plate. The 
plate containing the stock of diluted RNA was stored at -80°C 
c) The reverse transcription master mix was prepared as described in the kit (table A.5.1). All 
the components were allowed to thaw at 4°C before use 
d) 10 µL RT master mix was added to each well with diluted RNA. The plate was 
subsequently sealed with adhesive cover and centrifuged for 1 minute at 400 G. 
 Step 1 Step 2 Step 3 Step 4 
Temperature 25 °C 37 °C 85 °C 4 °C 
Time 10 min 120 min 5 min ∞ 
 
Table A.5.2: RT-PCR program. 
e) The cDNA synthesis was done using the Eppendorf Mastercycler Gradient (Eppendorf, 
Germany) at the conditions listed in table 2. 
f) Quantity and purity of synthesized cDNA was measured using the Nanodrop 1000 
Spectrophotometer as described in appendix A section A.3. 
g) cDNA was stored at -20°C until use. 
 
A.6 Protocol for qPCR 
Preparation of mastermix was done by thawing the components listed in table A.6.1 on ice, 
and mixing them thoroughly. A separate mastermix was prepared for every gene investigated 
in the qPCR (two for each run). One mastermix was pipetted into the first column of a 96 well 
PCR plate, and another mastermix in the second column. The plate was sealed with adhesive 
film and centrifuged at 800 g and 4 °C for 1 minute. 7 µL prepared mastermix was then 
pipetted into each well on a 384 well plate containing diluted cDNA by the Bravo Automated 
Liquid Handling Platform. 
Component Volume per reaction (µL) 
KAPA SYBR FAST Universal qPCR 
mastermix 
5.0 
Primer Forward 1.0 
Primer Reverse 1.0 
 
Table A.6.1: qPCR Mastermix 
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The qPCR was run using the BioRad CFX384 Touch real-time PCR detection system with the 
settings listed in table A.6.2. 
 
Step Temperature Time (minutes:seconds) 
1 95 °C 3:00 
2 95 °C 0:03 
3 60 °C 0:20 
Plate read - - 
4 72 °C 0:30 
5 GO TO step 2, 39 more times - - 
6 Melt curve 65 °C to 95 °C. 
Increment 0.5 °C 
0:05 
Plate read - - 
 
Table A.6.2: Run protocol for qPCR using the KAPA SYBR FAST qPCR mastermix. Program was run on 
the CFX384 Touch real-time PCR detection system. 
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A.7 Target genes and primer sequences 
Gene symbol Gene name Primer sequence forward Primer sequence forward 
Il-1α Interleukin 1 alpha CCACCAGCACAACTCTGAGATA CCCAATAACCCTGTCAATTTCTT 
Il-1β Interleukin 1 beta TTGGTTAAATGACCTGCAACA GAGCGCTCACGAACAGTTG 
Il-6 Interleukin 6 TGATGGATGCTACCAAACTGG TTCATGTACTCCAGGTAGCTATGG 
Tnf-α Tumor necrosis factor alpha CTGTAGCCCACGTCGTAGC TTGAGATCCATGCCGTTG 
Tnfsf13b Tumor necrosis factor ligand 
superfamily member 13b CGCCGACTATACGAAAAGGA CCTGTTTGCCTCACCACTATT 
Sod1 Superoxide dismutase 1 (soluble) CAGGACCTCATTTTAATCCTCA TGCCCAGGTCTCCAACAT 
Sod2 Superoxide dismutase 2 (mitochondrial) GACCCATTGCAAGGAACAA GTAGTAAGCGTGCTCCCACAC 
Sod3 Superoxide dismutase 3 (extracellular) GGGGAGGCAACTCAGAGG TGGCTGAGGTTCTCTGCAC 
Cat Catalase GGAGCAGGTGCTTTTGGATACT TCAGCTGAGCCTGACTCTCC 
Gpx1 Glutathione peroxidase 1 TTCGGACACCAGGAGAATGG TAAAGAGCGGGTGAGCCTTC 
Gpx2 Glutathione peroxidase 2 GTTCTCGGCTTCCCTTGC TTCAGGATCTCCTCGTTCTGA 
Nrf2 Nuclear factor (erythroid-derived 2)-like 2 CATGATGGACTTGGAGTTGC CCTCCAAAGGATGTCAATCAA 
Apex1 Apurinic/apyrimidinic 
endonuclease 1 CGGGGAAGAACCCAAGTC TCCTTCTCGGTTTTCTTTGC 
Neil1 Nei endonuclease VIII-like 1 (E.coli) TCGTAGACATCCGTCGCTTT TGTCTGATAGGTTCCGAAGTACG 
Neil2 Nei endonuclease VIII-like 2 (E.coli) CCAGAGCAAAGAAAGCTAACAAA ACCACCACTAAAATGGAGTACCA 
Neil3 Nei endonuclease VIII-like 3 (E.coli) GTGGTCTTCATCCGGCTGTT ATCCTGCTTTACAGCACCTG 
Cd47 Cluster of differentiation 47 CTGACCAAGGATCAGCCTGT CATTTGGAGAAAACCACGAAA 
Cd200 Cluster of differentiation 200 CTCTCCACCTACAGCCTGATTT CTGGGTCACCACTTCCACTT 
Cd200r1 Cluster of differentiation 200 
receptor 1 
AAGAATCAAACAACACAGAACAA
CA CTGTACAGACACTGTAGTGTTCACTTG 
Nox1 NADPH oxidase 1 ACCACTGGCTCTCAGTTTTGT GCCAAGGCAGTCCCAAGAA 
Nox4 NADPH oxidase 4 CCCTAAACGTTCTACTTTTCTGGA TGCTCTGCTTAAACACAATCCT 
Noxo1 NADPH oxidase organizer 1 TTCAGGCAGCTCCAGAAGAC TGTCAGCAATGGAGCATCAG 
Table A.7: Target genes for qPCR with symbols, names and primer sequences. 
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Appendix B: Solutions and media 
B.1 Cell culture medium 
- 500 mL Dulbecco’s Modified Eagle’s Medium, with 4.5 g/L Glucose, without L-Glutamine. 
- 55 mL (10%) Foetal Calf Serum 
- 5.5 mL (1%) Penicillin-Streptomycin 
- 5.5 mL (1%) L-Glutamine (200 mM) 
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Appendix C: Products and producers 
Product      Producer   Country 
 
2100 Bioanalyzer     Agilent Technologies  USA 
96-well PCR Plate Non-skirted   4titude    UK 
Absolutt alkohol prima (100 % (absolute)   Kementyl Norge  Norway 
ethanol) 
BioWhittaker® Dulbecco’s Modified Eagle’s  Lonza    Belgium 
Medium, with 4.5 g/L Glucose, without 
L-Glutamine 
BioWhittaker® L-Glutamine 200mM  Lonza    Belgium 
BioWhittaker® PEN-STREP    Lonza    Belgium 
(penicillin-streptomycin) 
BioWhittaker® Trypan Blue 0.4%   Lonza    Belgium 
BioWhittaker® Trypsin EDTA   Lonza    Belgium 
Bovine Serum Albumin, Fraction V   Sigma-Aldrich  USA 
Bravo Automated Liquid Handling Platform Agilent Technologies  USA 
Centrifuge tubes 15 mL    Corning   USA 
TPP    Switzerland 
Centrifuge tubes 50 mL    Corning   USA 
Greiner Bio-One  Austria 
Corning flasks (25 cm2, 75 cm2, 162 cm2)  Corning   USA 
Costar Assay Plate 96 well Black with clear  Corning   USA 
flat bottom 
CFX384 Touch real-time PCR detection system Bio-Rad   USA 
DCF-DA      Sigma-Aldrich  USA 
Distilled water (dH2O)    Locally produced, NIPH Norway 
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Eppendorf Mastercycler Gradient   Eppendorf   Germany 
Eppendorf tubes 1.5 mL    VWR    USA 
GenElute Mammalian Total RNA Miniprep Kit Sigma-Aldrich  USA 
Hard shell PCR plate 384 well   Bio-Rad   USA 
High-Capacity cDNA Reverse Transcription Kit  Applied Biosystems   USA 
Hydrogen Peroxide 30%    Merck KGaA   Germany 
JC-1 Mitochondrial Membrane Potential Assay  Cayman Chemical  USA 
Kit 
KAPA SYBR FAST qPCR Kit   Kapa Biosystems  USA 
Microtubes 1.5 mL EasiFit Black   Treff    Switzerland 
Nanodrop 1000     Nanodrop Technologies USA 
Phosphate buffered saline (PBS)   Locally produced, NIPH Norway 
Precellys 24 tissue homogenizer   Bertin Technologies  France 
RNA 6000 Nano Assay Kit    Agilent technologies  USA 
RNase Away      Molecular BioProducts USA 
Silver particles (Ag20 and Ag200)   Plasmachem   Germany 
UltraTurrax      IKA-Werke   Germany 
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Appendix D: Additional results 
D.1 Reference gene stability 
 
 
Figure D.1: Stability of reference genes in WT (A) and KO (B) brain. (A) WT Treatment groups are day 1 
control (n=6), Ag20 (n=6), Ag200 (n=6); day 7 control (n=5), Ag20 (n=6), Ag200 (n=5); (B) KO treatment 
groups are day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); day 7 control (n=5), Ag20 (n=6), Ag200 (n=5). 
Values are presented as average raw Cq-value of treatment groups ± SEM. 
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Figure D.2: Stability of reference genes in WT (A) and KO (B) testis. (A) WT Treatment groups are day 1 
control (n=6), Ag20 (n=6), Ag200 (n=6); day 7 control (n=5), Ag20 (n=6), Ag200 (n=5); (B) KO treatment 
groups are day 1 control (n=6), Ag20 (n=6), Ag200 (n=6); day 7 control (n=5), Ag20 (n=6), Ag200 (n=5). 
Values are presented as average raw Cq-value of treatment groups ± SEM. 
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D.2: RNA quantity and quality in relation to genotype, time and treatment. 
 
 
 
 
 
 
 
 
 
 
Figure D.2.1: RNA quality and purity in relation to genotype. (A) RNA yield µg RNA/mg tissue, (B) 
OD260/280, (C) OD260/230. Sample sizes are brain KO n=36, brain WT n=34; liver KO n=36, liver WT n=34;  
lung KO n=36, brain WT n=34;  testis KO n=36, brain WT n=34. n=number of animals. 
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Figure D.2.2: RNA quality and purity in relation to time (experiment day). (A) RNA yield µg RNA/mg tissue, 
(B) OD260/280, (C) OD260/230. Sample sizes are brain day1 n=36, brain day7 n=34; liver day1 n=36, brain 
day7 n=34;  lung day1 n=36, brain day7 n=34; testis day1 n=36, brain day7 n=34; n=number of animals. 
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Figure D.2.3: RNA quality and purity in relation to treatment. (A) RNA yield µg RNA/mg tissue, (B) 
OD260/280, (C) OD260/230. Vehicle represents the control group. Sample sizes are brain Ag20 n=24, brain 
Ag200 n=23, brain vehicle (control) n=23; liverAg20 n=24, liver Ag200 n=23, liver vehicle (control) n=23; 
lung Ag20 n=24, lung Ag200 n=23, lung vehicle (control) n=23; testis Ag20 n=24, testis Ag200 n=23, testis 
vehicle (control) n=23. n= number of animals.  
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